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Cells of the human intestinal tract mapped 
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Michael D. Morgan8,9, John C. Marioni1,8,9, Omer Ali Bayraktar1, Kerstin B. Meyer1, 
Xiaoling He10, Roger A. Barker10, Holm H. Uhlig11,12,13, Krishnaa T. Mahbubani14, 
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The cellular landscape of the human intestinal tract is dynamic throughout life, 
developing in utero and changing in response to functional requirements and 
environmental exposures. Here, to comprehensively map cell lineages, we use 
single-cell RNA sequencing and antigen receptor analysis of almost half a million  
cells from up to 5 anatomical regions in the developing and up to 11 distinct 
anatomical regions in the healthy paediatric and adult human gut. This reveals the 
existence of transcriptionally distinct BEST4 epithelial cells throughout the human 
intestinal tract. Furthermore, we implicate IgG sensing as a function of intestinal tuft 
cells. We describe neural cell populations in the developing enteric nervous system, 
and predict cell-type-specific expression of genes associated with Hirschsprung’s 
disease. Finally, using a systems approach, we identify key cell players that drive  
the formation of secondary lymphoid tissue in early human development. We show 
that these programs are adopted in inflammatory bowel disease to recruit and  
retain immune cells at the site of inflammation. This catalogue of intestinal cells will  
provide new insights into cellular programs in development, homeostasis and 
disease.
Intestinal tract physiology relies on the integrated contribution of mul-
tiple cell lineages, the relative abundance and cell networking of which 
fluctuate from embryonic development to adulthood. Further complex-
ity is added because the intestinal tract is formed of distinct anatomical 
regions that develop at different rates and carry out diverse roles in 
digestion, nutrient absorption, metabolism and immune regulation.
The analysis of rare fetal tissues has resolved the formation of villi–
crypt structures and the seeding of immune cells into the gut environ-
ment1–3. Similarly, our understanding of the cellular landscape of the 
adult gut is benefiting from single-cell technologies. Regional differ-
ences in immune-cell activation and microbiome composition in the 
healthy human colon have previously been reported4. Studies that 
compare inflammatory bowel disease samples to healthy tissues have 
enabled the identification of disease-relevant stromal5,6, tissue-resident 
CD8 T cell7–9 populations and correlation between cellular response 
and clinical treatment10. Although extensive work has been carried out 
to profile the intestinal tract at single-cell resolution (Supplementary 
Table 1), a holistic analysis of the gut through space (anatomical location) 
and time (lifespan) is lacking. Building such a developmental roadmap 
would be invaluable for the scientific community11.
Here we create a single-cell census of the healthy human gut, encom-
passing around 428,000 cells from the small and the large intestines as 
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well as associated lymph nodes during in utero development, childhood 
and adulthood.
Integrated map of human intestinal cells
To investigate cellular dynamics across the intestinal tract, we per-
formed single-cell RNA sequencing (scRNA-seq) on distinct tissue 
regions of second-trimester (12–17 post-conception weeks (PCW)) 
and adult (29–69 years) intestines and draining mesenteric lymph 
nodes (mLN) (Fig. 1a, Extended Data Fig. 1a). Additionally, we integrated 
results from the scRNA-seq analysis of tissues from first-trimester (6–11 
PCW) intestine, paediatric Crohn’s disease and healthy ileum1.
The dataset comprised more than 428,000 high-quality cells 
(Extended Data Fig. 1b, Supplementary Table 2). Leiden clustering 
and marker-gene analysis revealed major clusters of epithelial, mes-
enchymal, endothelial, immune, neural and erythroid cells (Fig. 1b, 
Extended Data Fig. 1c). Fetal gut samples were enriched for mesenchy-
mal and neural cells, with increased abundance of immune cells from 
the second trimester onwards in gut and mLN (Fig. 1b, Extended Data 
Fig. 1d–f). Further sub-clustering of the cellular lineages enabled the 
identification of 133 cell types and states with specific transcriptional 
identities (Extended Data Fig. 2a, Supplementary Tables 3–7).
BEST4 epithelial cells, which have been previously observed in 
human small and large intestines6,12,13, varied in abundance between 
intestinal regions (Fig. 1c, d). Using differential cell-type abundance 
analysis14, we identified their region-specific expression signatures 
(Fig. 1e, Extended Data Fig. 3a–d). Notably, small-intestinal BEST4 cells 
were marked by high expression of the gene CFTR, which encodes a 
chloride channel and is mutated in cystic fibrosis (Fig. 1e); such high 
expression was also observed at the protein level (Extended Data 
Fig. 3e). In this staining and in previous work, BEST4 cells were in 
close proximity to cells that resembled goblet cells12 (Extended Data 
Fig. 3f). Our analysis highlights a possible role of BEST4 enterocytes 
of the small intestine in aiding mucus production by goblet cells 
and biosynthesis of acids, in contrast to the functions of colonic 
BEST4 cells in the metabolism of small molecules (Extended Data 
Figs. 3g, 4a, b).
Diversity of intestinal epithelial cells
In the epithelial compartment, secretory cells consisted of goblet, 
tuft, Paneth and microfold cells, as well as precursor states. Absorptive 
and goblet cells showed regional separation at all life stages (Fig. 2a, b, 
Extended Data Figs. 5a–c, 6a, b). Given that the gut epithelium repre-
sents an entry point for SARS-CoV-215, we also report that both ACE2 
and TMPRSS2—which encodes transmembrane serine protease 2—were 
expressed by enterocytes in early development (Fig. 2c, Extended Data 
Fig. 6c).
Subclustering of enteroendocrine cells (EECs) revealed NEU-
ROG3-expressing precursor cells enriched in the first-trimester fetal 
gut, and multiple mature subsets resembling populations described 
in intestinal organoids16 (Fig. 2d, Extended Data Fig. 6d). Although 
neuropeptide W (encoded by NPW) is known to stimulate food intake17 
and is broadly expressed by EECs16,18, we found a subpopulation of 
NPW-expressing enterochromaffin cells that are also specific for PRAC1 
and RXFP4 (Extended Data Fig. 4d). We delineated genes involved in 
the differentiation of NEUROG3 precursors to enterochromaffin cells, 
including recently described genes (marked by arrows) such as FEV19,20 
(Fig. 2e, Extended Data Fig. 6e, f).
Notably, among the top differentially expressed genes in tuft cells 
was PLCG2 (Extended Data Fig. 6g, h), a phospholipase that is typi-
cally associated with haematopoietic cells. To explore the relevance 
of PLCG2 in tuft cells, we screened for the expression of upstream 
receptors (Fig. 2f, Extended Data Fig. 6i). FCGR2A, which is activated 
in response to IgG and expressed by selected epithelial cells in immu-
nized mice21, was specifically expressed by approximately 2.75% of tuft 
cells (Fig. 2f). We confirmed the expression of the protein FCGR3 (the 
mouse orthologue of human FCGR2A) by approximately 5% of small 
intestinal tuft cells in mice (Fig. 2g, Extended Data Fig. 6j). Receptor 
tyrosine kinases were expressed across tuft cells and other epithelial 
cell types. Because these are known to be mainly linked to PLCG1 activa-
tion, whether they are also responsible for PLCG2 activation in tuft cells 
is difficult to delineate (Fig. 2h). PLCG2 expression by tuft cells was at 
higher levels than in B and myeloid lineages, and was confirmed in both 
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Fig. 1 | Intestinal cellular census throughout life. a, Schematic of human gut 
tissue sampling. Number of donors sampled for scRNA-seq is given. Mid., 
middle; prox., proximal; term., terminal; mLN, mesenteric lymph node; jej., 
jejunum; duo., duodenum; trans., transverse; asc., ascending; desc., 
descending; sig., sigmoid. b, Relative proportions of cell lineages at each 
developmental stage. NK, natural killer; CD, inflammatory bowel disease.  
c, Proportions of BEST4-expressing enterocytes among epithelial cells 
in scRNA-seq data of each tissue region and at each developmental stage. Ile., 
ileum; app., appendix; cae., caecum; rec., rectum. d, Expression of BEST4 in 
histological sections, from https://proteinatlas.org48 (Supplementary Table 8, 
n = 2 biologically independent samples for each region). Scale bars, 50 µm.  
e, Dot plot with relative expression of selected genes within BEST4 epithelial 
cells from different locations and ages. Key genes are highlighted in red, and 
the full Milo analysis can be found in Extended Data Fig. 3d.
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with downstream signalling mediators including RAC2, ITPR2, PRKCA 
and TRPM5 (Fig. 2f, h)—suggested the ability of tuft cells to respond 
to immune-cell signalling.
Development of the enteric nervous system
Next we investigated the differentiation of neural cells from enteric 
neural crest cell (ENCC) progenitors (Fig. 3a, b) that were present in 
the dataset from 6.5 PCW (Extended Data Fig. 8a). ENCCs balance 
proliferation and differentiation into glia and neurons, while main-
taining a progenitor reserve. To capture discrete processes of ENCC 
differentiation, we analysed early (6–11 PCW) and late (12–17 PCW) 
development separately (Extended Data Fig. 8b). In early development, 
ENCCs differentiated primarily to neurons via neuroblasts, giving rise 
to two distinct branches: branch A (ETV1) and branch B (BNC2) (Fig. 3a, 
Extended Data Figs. 8c, 9a–d), as has been observed in mice22. At this 
stage, branch A further differentiated to inhibitory motor neurons 
(iMN, resembling ENC8–ENC922) and two subsets that had character-
istics of intrinsic primary afferent neurons (IPANs) or interneurons 
(resembling ENC1222) with similarity to cells observed in the human 
fetal gut3 (Extended Data Fig. 8d). Branch B further differentiated to 
immature excitatory motor neuron (eMN) subsets (branches B1 and 
B2, resembling ENC1–ENC322) (Fig. 3a).
At later development, branch A differentiated into NEU-
ROD6-expressing interneurons (resembling ENC1022), whereas branch 
B differentiated into IPANs (Fig. 3b, Extended Data Figs. 8c, 9a–d) simi-
lar to previously described adult human IPAN A cells23. We visualize 
opposing expression of SCGN (branch A1) and GRP (branch A2 and A3) 
and BNC2 (branch B1 and B2) in the developing and adult human 
myenteric plexus (Fig. 3c, Extended Data Fig. 8e). The expression of 
transcription factors, such as ETV1, was previously validated in situ in 
a complementary resource of the human gut24.
Although differentiated neurons were abundant at 6–11 PCW, glial 
cells were enriched at later development. Three types of enteric 
neural and a subset of differentiating glia (COL20A1) were present 
at 12–17 PCW (Fig. 3b, Extended Data Fig. 9a–d). Colonic glia 1 cells 
expressed posterior HOX genes and TFAP2B, which suggests that 
they originated in the sacrum or trunk (Extended Data Fig. 8g). We 
visualized BMP8B-expressing cells in the myenteric plexus, whereas 
DHH-expressing cells were found both in the mesentery and the myen-
teric plexus (Fig. 3d, Extended Data Fig. 8f).
To identify neural cells involved in Hirschsprung’s disease (HSCR), 
we screened for the expression of known HSCR-associated genes25–27. 
The majority of HSCR-associated genes were expressed across mul-
tiple differentiating populations with varying intensity (Fig. 3e), and 
varied between neuron branches A and B. For example, RET was highly 
expressed by branch A, but not by branch B, neurons. Notably, ZEB2 and 
EDNRB were more highly expressed across colonic glia and neuroblast 
subsets compared to equivalent small intestinal subsets (Fig. 3e). Any 
differences in expression between regions might also be due to the 
developmental lag of the large intestines. In addition, key ligands that 
are implicated in HSCR—including GDNF, NRTN and EDN3—were primar-
ily expressed by mesothelium, smooth muscle cells and interstitial cells 
of Cajal (ICC) (Extended Data Fig. 8h).
Formation of secondary lymphoid organs
Gut-associated lymphoid tissues and mLN are key sites of gut immune 
surveillance. We observed mLN emergence at around 12 PCW, with 
structures disectable from 15 PCW (Extended Data Fig. 10a)—consist-
ent with previous observations28. Interactions between mesenchymal 
and endothelial lymphoid tissue organizers (mLTo and eLTo, respec-
tively) and lymphoid tissue inducers (LTi) are central to initiating the 
formation of secondary lymphoid organs29. To better understand 
this process in humans, we assessed our dataset for the key cell types 
involved.
Sub-clustering of fetal and adult T and innate lymphoid cells 
revealed three clusters that matched published characteristics of 












































































































































































































































































































































Fig. 2 | Epithelial cells and FCGR2A signalling in tuft cells. a, b, Uniform 
manifold approximation and projection (UMAP) of fetal (a) and postnatal  
(b) epithelial cell types. Key cell types are circled with a dashed line and arrows 
depict paths of differentiation towards secretory and absorptive enterocytes 
as determined by scVelo. M cells, microfold cells; TA, transit-amplifying. c, Dot 
plot of TMPRSS2 and ACE2 expression in epithelial cells in the fetal intestine as 
in a. d, UMAP of enteroendocrine (EEC) and enterochromaffin (EC) cell subsets. 
Arrows depict summarised scVelo differentiation trajectories. C9orf16 is also 
known as BBLN. e, Heat map of genes that change along the differentiation 
trajectory from NEUROG3-expressing progenitors to enterochromaffin cells 
(red arrow in d). Arrows indicate genes that have known associations with 
enterochromaffin cell differentiation. f, Dot plot with expression of molecules 
upstream or downstream of the PLCG2 pathway in tuft cells and pooled 
absorptive (TA and enterocytes) and secretory (Paneth, goblet and EEC) cells. 
g, Per cent expression of Fcγ receptor by SiglecF+EpCAM+ and SiglecF−EpCAM+ 
cells in wild-type mice determined by flow cytometry (individual points 
represent biological replicates; n = 4). Using a two-way ANOVA we observe 
significant interaction between Fcγ receptor expression (F(3, 39) = 42.29, 
P = 3.05 × 10−11). Post-hoc analysis showed significant differences between 
non-Tuft epithelial cells and Tuft cells for FcγRIIB (mean difference = 2.80, 95% 
CI [1.80, 3.81], P < 0.0001) and FcγRIIB/III (mean difference = 4.88, 95% CI [3.88, 
5.89], P < 0.0001) expression. ****Padj < 0.0001 values corrected with Tukey’s 
test for multiple comparisons. h, Schematic of proposed signalling pathways in 
tuft cells. RTK, receptor tyrosine kinases.
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LTA, LTB, IL7R and ITGB7 (beta chain of gut-specific α4β7 integrin) as 
well as the absence of productive αβ TCR (Extended Data Figs. 10b–d, 
11a–c). Innate lymphoid cell progenitors (ILCPs) were transcription-
ally comparable to fetal liver ILCPs30 (Extended Data Fig. 10e), and 
were found both in fetal mLN and in embryonic gut, whereas NCR+ 
and NCR− type 3 innate lymphoid cells (ILC3s) were expanded across 
gut regions throughout 6–17 PCW (Extended Data Fig. 10f). This 
suggests that LTi-like ILC3 subsets are expanded during the develop-
ment of gut-associated lymphoid tissues, but not during the devel-
opment of mLN. Single-molecule fluorescence in situ hybridization 
(smFISH) staining identified all three LTi-like subtypes (Extended Data 
Fig. 10g) and placed CXCR5 and RORC-expressing LTi cells adjacent to 
CXCL13-expressing LTo cells in proximal gut mucosa (Fig. 4c), supporting 
the concept of congregation of these cells in the developing gut. These 
observations—together with the expression of genes that encode 
key chemokines (CXCR5, CCR7 and CCR6) and RNA velocity analysis 
(Extended Data Fig. 10h)—suggests that ILCPs are the first LTi-like cells 
in the developing gut, and represent a progenitor state to ILC3s.
We observed arterial, venous, capillary and lymphatic endothe-
lial cells (LECs) (Extended Data Figs. 2a, 12a, b). LECs separated into 
six clusters (labelled LEC1–LEC6; Extended Data Fig. 12c). LEC2 cells 
expressed TNFRSF9, THY1, CXCL5 and CCL20—as described in human 
lymph nodes31—as well as targets of the NF-κB pathway and adhesion 
molecules including MADCAM1, VCAM1 and SELE, suggesting their 
involvement in lymphocyte trafficking (Extended Data Fig. 12d, e). We 
confirmed that the presence of high endothelial venule structures was 
required for lymphocyte entry and for proximity of PROX1+ vessels to 
CXCL13+ mLTo and RORC+ LTi cells (Extended Data Fig. 12f, g).
Within the stromal compartment, we identified subtypes of myofi-
broblast, smooth muscle cells, pericyte, interstitial cells of Cajal, 
mesothelium and populations resembling stromal cells previously 
described in the colon5 (labelled as stromal 1–4) (Fig. 4d, Extended Data 
Fig. 2a). We further identified fibroblast populations typically defined in 
mouse lymph nodes32, including T reticular cells and follicular dendritic 
cells (Extended Data Fig. 13a). In the prenatal intestine and mLN, we 
observed a stromal population—marked by the expression of CCL19, 
CCL21 and CXCL13 as well as adhesion and NF-κB pathway molecules 
(Extended Data Fig. 13b–f)—that resembled the mLTo described in 
mouse lymph nodes33. We further determined cell–cell interactions that 
governed early leukocyte recruitment across LEC2, mLTo and LTi-like 
cells (Extended Data Fig. 13g, h), and differences in B cell activation 
status between fetal and adult samples (Extended Data Fig. 14a–l).
To visualize the recruitment of naive immune cell subsets to acti-
vated mLTo, we used cell2location34 to perform spatial mapping of 
single-cell transcriptomes to 10x Genomics Visium spatial zones in 
17 PCW fetal ileums (Fig. 4e, Methods). In this analysis, we captured 
tissue zones with expression of mLTo marker genes (CCL19, CCL21 and 
CXCL13) (Extended Data Fig. 15a–c) that were likely to correspond to 
developing secondary lymphoid organs. We found that LEC2, mLTo 
and LTi-like subsets mapped to the same tissue zones as naive immune 
subsets (for example, SELL CD4 T cells, T regulatory cells, immature B 
cells; tissue zone or fact_11 (Extended Data Fig. 15c)). M cells character-
istic of secondary lymphoid organs were present in the adjacent zone 
(tissue zone or fact_5 (Extended Data Fig. 15c)).
Following our observations, we compared programs of lymphoid 
organogenesis with the formation of ectopic lymphoid structures that 
is observed in patients with Crohn’s disease35. We found that ILC3s in 
tissues from patients with Crohn’s disease matched fetal NCR+ ILC3s 
with more than 60% probability, whereas T reticular cells and stromal 4 
cells from patients with Crohn’s disease transcriptionally reassembled 
fetal mLTo (Extended Data Fig. 15d, e) and were expanded in four out of 
seven Crohn’s disease samples (Extended Data Fig. 13b). Finally, from 
a genome-wide association study across cell types in our dataset, we 
calculated the enrichment score for genes associated with Crohn’s dis-
ease and ulcerative colitis (with a false-discovery rate of 10%; Methods). 
Adult ILC3s and fetal ILCPs and NCR+ ILC3s were among the top cells 
that were enriched for the expression of genes associated with Crohn’s 
disease (Fig. 4f, Extended Data Fig. 15f).
Discussion
Here we present an integrated dataset of more than 428,000 single 
cells from multiple anatomical regions of the human gut throughout 
life. This dataset can be browsed at https://gutcellatlas.org.
We found that FCGR2A, which encodes a receptor activated by the 
Fc fragment of IgG upstream of PLCG2, is expressed by a subset of tuft 
cells. In the context of development, IgG has been shown to traverse the 






































































































































































































































Fig. 3 | Cells of the developing enteric nervous system. a, b, UMAP of enteric 
neural crest cells (ENCC) and their progeny at 6–11 (a) and 12–17 (b) PCW. 
Overlaid arrows depict scVelo trajectories, with major neuronal branches 
shown as A and B. Marker genes for populations are listed. Branch A2 and A3 
subsets were not observed at 12–17 PCW, possibly because they were 
outnumbered by the glial populations. c, d, Multiplex smFISH staining of SCGN 
branch A1, GRP branch A2/A3 and BNC2 branch B1/2 developing ELAVL4 
neurons (arrows, n = 2) in the 15 PCW ileum (scale bars, 100 µm) (c) and glia 1 
(DHH, MPZ, SOX10) cells in the mesentery (scale bars: main, 100 µm; expansion, 
30 µm. n = 2 (d)). n represents the number of biological replicates across 
regions. e, Heat map showing the mean expression of genes associated with 
HSCR across intestinal regions and developmental stages. iMN, inhibitory 
motor neuron; IPAN, primary afferent neurons; IN, interneurons, int., intestine.
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in utero. Two missense variants of PLCG2 have been linked to aberrant 
B cell responses in early-onset inflammatory bowel disease36,37 and 
primary immune deficiency38. Here we show increased expression of 
FcγRIIB (human FCGR2B)—which encodes an inhibitory receptor—by tuft 
cells in a mouse model of colitis, suggesting another possible involve-
ment for this pathway in inflammatory bowel disease through tuft cells. 
Overall, these data suggest a potentially impactful immune-sensing role 
for intestinal tuft cells, and a topic for further investigation in future.
Immune sensing in the intestines also occurs in secondary lymphoid 
organs, and although there are substantial differences in the size and 
location of secondary lymphoid organs between species39, our under-
standing of the formation of these structures is mostly derived from ani-
mal models29. Single-cell studies have begun to elucidate the diversity 
and activation of immune cells in the developing human gut3,40,41. Here 
we identify cell types in the developing intestines that have transcrip-
tional signatures and signalling pathways matching LTi, mLTo and eLTo 
(LEC2) cells. In vitro studies have shown the ability of RORC-expressing 
CD56+CD127+IL17A+ cells42 and ILC3s43 to activate mesenchymal cells. 
This leads us to propose that all three LTi-like subsets defined in this 
study act in the initiation of secondary lymphoid organs, but probably 
at different stages of the process. Future studies using complementary 
approaches will shed light on these cell states and their tissue architec-
ture. Notably, we also observe two specialized fibroblast populations 
in paediatric Crohn’s disease—follicular dendritic cells and T reticu-
lar cells—similar to cells described in mouse lymph nodes32, Peyer’s 
patches44–47 and those expanded in patients with ulcerative colitis5 as 
well as patients with Crohn’s disease1,10.
Overall, our work provides clarity on the complex interplay between 
intestinal cell types throughout time and space, and has potential impli-
cations for disease and for the engineering of in vitro systems.
Online content
Any methods, additional references, Nature Research reporting sum-
maries, source data, extended data, supplementary information, 
acknowledgements, peer review information; details of author con-
tributions and competing interests; and statements of data and code 
availability are available at https://doi.org/10.1038/s41586-021-03852-1.
1. Elmentaite, R. et al. Single-cell sequencing of developing human gut reveals 
transcriptional links to childhood Crohn’s disease. Dev. Cell 55, 771–783.e5 (2020).
2. Holloway, E. M. et al. Mapping development of the human intestinal niche at single-cell 
resolution. Cell Stem Cell 28, 568–580.e4 (2021).
3. Fawkner-Corbett, D. et al. Spatiotemporal analysis of human intestinal development at 
single-cell resolution. Cell 184, 810–826.e23 (2021).
4. James, K. R. et al. Distinct microbial and immune niches of the human colon. Nat. 
Immunol. 21, 343–353 (2020).
5. Kinchen, J. et al. Structural remodeling of the human colonic mesenchyme in 
inflammatory bowel disease. Cell 175, 372–386.e17 (2018).
6. Smillie, C. S. et al. Intra- and inter-cellular rewiring of the human colon during ulcerative 
colitis. Cell 178, 714–730.e22 (2019).
7. Boland, B. S. et al. Heterogeneity and clonal relationships of adaptive immune cells in 
ulcerative colitis revealed by single-cell analyses. Sci. Immunol. 5, eabb4432 (2020).
8. Corridoni, D. et al. Single-cell atlas of colonic CD8+ T cells in ulcerative colitis. Nat. Med. 
26, 1–11 (2020).
9. Huang, B. et al. Mucosal profiling of pediatric-onset colitis and ibd reveals common 
pathogenics and therapeutic pathways. Cell 179, 1160–1176.e24 (2019).
10. Martin, J. C. et al. Single-cell analysis of Crohn’s disease lesions identifies a pathogenic 
cellular module associated with resistance to anti-TNF therapy. Cell 178, 1493–1508.e20 
(2019).
11. Haniffa, M. et al. (2021) A roadmap for the Human Developmental Cell Atlas. Nature, 
https://doi.org/10.1038/s41586-021-03620-1 (2021).
12. Ito, G. et al. Lineage-specific expression of bestrophin-2 and bestrophin-4 in human 
intestinal epithelial cells. PLoS ONE 8, e79693 (2013).
13. Parikh, K. et al. Colonic epithelial cell diversity in health and inflammatory bowel disease. 
Nature 567, 49–55 (2019).
14. Dann, E., Henderson, N. C., Teichmann, S. A., Morgan, M. D. & Marioni, J. C. Milo: 
differential abundance testing on single-cell data using k-NN graphs. Preprint at  
https://doi.org/10.1101/2020.11.23.393769 (2020).
15. Lamers, M. M. et al. SARS-CoV-2 productively infects human gut enterocytes. Science 
369, 50–54 (2020).
16. Beumer, J. et al. High-resolution mRNA and secretome atlas of human enteroendocrine 
cells. Cell 181, 1291–1306.e19 (2020).
17. Levine, A. S., Winsky-Sommerer, R., Huitron-Resendiz, S., Grace, M. K. & de Lecea,  
L. Injection of neuropeptide W into paraventricular nucleus of hypothalamus increases 
food intake. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288, R1727–R1732 (2005).
18. Roberts, G. P. et al. Comparison of human and murine enteroendocrine cells by 
transcriptomic and peptidomic profiling. Diabetes 68, 1062–1072 (2019).
19. Gehart, H. et al. Identification of enteroendocrine regulators by real-time single-cell 















































































































































































0 1 2 3
Log odds ratio
*Cell types with
FDR < 10% in UC
Fig. 4 | Lymphoid tissue organogenesis programs adopted in Crohn’s 
disease. a, UMAP of T and innate cells in scRNA-seq data across development. 
Dotted line denotes LTi-like cells and listed are characteristic genes.  
b, Schematic showing expression signatures of identified LTi-like states.  
c, Multiplex smFISH of 15 PCW ileum showing proximity of RORC CXCR5- 
expressing LTi-like cells to CXCL13-expressing mLTo cells (n = 2 biological 
replicates across regions). Arrows highlight cells of interest. Scale bars: main, 
100 µm; expansion, 50 µm. d, UMAP of stromal cell types across development. 
The dotted line highlights key lineages. e, Spatial mapping of cell types from 
the scRNA-seq data to spatial transcriptomics data of 17 PCW terminal ileum 
using cell2location34. Estimated abundance for cell types (colour intensity) 
across locations (dots) is overlaid on a histology image for LEC2 (left), LTi-like 
ILC3 (middle) and microfold (right) cells. f, Heat map showing top cell types 
across fetal, paediatric (healthy and Crohn’s disease) and adult data that are 
enriched for gene expression associated with either Crohn’s disease or 
ulcerative colitis (UC). All cell types listed are FDR < 10% for Crohn’s disease. 
Asterisks denote cell types with FDR < 10% for ulcerative colitis. CLP, common 
lymphoid progenitor.
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Methods
No statistical methods were used to predetermine sample size. The 
experiments were not randomized and the investigators were not 
blinded to allocation during experiments and outcome assessment.
Patient samples
The research complies with all relevant ethical regulations and 
guidelines. Informed consent was obtained from all human partici-
pants and includes consent to publish photographs included in fig-
ures. Maternal consent and fetal gut samples were obtained through 
Newcastle upon Tyne Hospitals NHS Foundation Trust, the Human 
Developmental Biology Resource (HDBR, https://www.hdbr.org), or 
through Addenbrooke’s Hospital, Cambridge in collaboration with 
R. A. Barker. Procurement and study of fetal samples were approved 
by REC18/NE/0290- IRAS project ID: 250012, North East - Newcastle & 
North Tyneside 1 Research Ethics Committee and REC-96/085, East of 
England - Cambridge Central Research Ethics Committee.
Paediatric patient material used in intestinal organoid culture was 
obtained with informed consent from either parents and/or patients 
using age-appropriate consent and assent forms as part of the ethically 
approved research study (REC-12/EE/0482, NRES Committee East of 
England, Hertfordshire and REC-17/EE/0265- IRAS project ID: 222907, 
East of England - Cambridge South Research Ethics Committee).
Human adult tissue was obtained by the Cambridge Biorepository of 
Translational Medicine from deceased transplant organ donors after 
ethical approval (reference 15/EE/0152, East of England - Cambridge 
South Research Ethics Committee) and informed consent from the 
donor families. Details of the ages and genders of donors are included 
as Supplementary Table 2. Samples were collected from 11 distinct loca-
tions, including the duodenum (two locations, DUO1 and DUO2, which 
were pooled in the analysis), jejunum ( JEJ), ileum (two locations, ILE1 
and ILE2, which were pooled in the analysis), appendix (APD), caecum 
(CAE), ascending colon (ACL), transverse colon (TCL), descending colon 
(DCL), sigmoid colon (SCL), rectum (REC) and mesenteric lymph nodes 
(mLN). Fresh mucosal intestinal tissue and lymph nodes from the intes-
tinal mesentery were excised within 1 h of circulatory arrest; intestinal 
tissue was preserved in University of Wisconsin organ-preservation 
solution (Belzer UW Cold Storage Solution; Bridge to Life) and mLN 
were stored in saline at 4 °C until processing. Tissue dissociation was 
conducted within 2 h of tissue retrieval.
Mouse samples
C57BL/6 mice were obtained from Jackson Laboratories and maintained 
in specific-pathogen-free conditions at a Home-Office-approved facility 
at the University of Cambridge. Female mice aged 10–14 weeks were 
used; the numbers of mice used are included in the relevant figure 
legends. All procedures were carried out in accordance with ethical 
guidelines with the United Kingdom Animals (Scientific Procedures) Act 
of 1986 and approved by The University of Cambridge Animal Welfare 
and Ethical Review Body.
Isolation of intestinal cells from fetal tissue
The fetal gut mesentery was cut to lengthen out the tissue and the gut was 
dissected into proximal ileum (PIL), middle ileum (MIL), terminal ileum 
(TIL), colon or large intestine (LI) and appendix. Samples, except appendix, 
were washed twice with Hanks Buffered Saline Solution (HBSS; Sigma-
Aldrich, 55021C) and minced into pieces using a scalpel. The samples 
were incubated in 2 ml HBSS solution containing 0.21 mg ml−1 Liberase 
TL (Roche, 5401020001) or DH (Roche, 5401089001) and 70 U ml−1 
hyaluronidase (Merck, 385931-25KU) for up to 50 min at 37 °C, shaking 
every 5 min, and homogenized every 15 min using a pipette. The single 
cells were passed through a 40–100 µm sieve and spun down at 400g at 
4 °C for 10 min. Red cell lysis solution (eBioscience10X RBC Lysis Buffer 
(Multi-species)) was used according to the manufacturer’s guidelines 
to remove red blood cells, and the remaining cells were collected in 
FACS buffer (1% (v/v) FBS in PBS) by centrifugation at 400g at 4 °C for 
5 min. All gut region samples (except mLN) proceeded to enrichment 
by magnetic-activated cell sorting (MACS).
Isolation of intestinal cells from adult tissue
Adult tissue sections were weighed before being washed in cold D-PBS 
(Gibco, 14190094) and diced with a scalpel. Samples were dissociated 
in 1–2 ml of digestion mix (D-PBS, 250 µg ml−1 Liberase TL (Roche, 
5401020001), 0.1 mg ml−1 DNaseI (Sigma, 11284932001)) or DH (Roche, 
5401089001) and 70 U ml−1 hyaluronidase (Merck, 385931-25KU) for up 
to 30 min at 37 °C. Digested lysates were then passed through a 70 µm 
cell strainer, followed by 10 ml of neutralization medium (RPMI 1640 
medium with HEPES (Gibco, 42401042), 20% (v/v) FBS (Sigma, 25200-
056)). The samples were then centrifuged at 700g for 5 min at 4 °C. 
Cells were resuspended in 1 ml 0.04% (w/v) BSA in D-PBS and counted 
using a NucleoCounter NC-200 and Via1-Cassette (ChemoMetec). All 
gut region samples (except mLN) proceeded to MACS enrichment.
MACS enrichment
Samples with a cell yield of greater than 500,000 were enriched by 
MACS. Dissociated cells were centrifuged for 5 min at 300g at 4 °C 
and resuspended in 80 µl chilled MACS buffer (D-PBS, 0.5% (w/v) BSA 
(Sigma-Aldrich, A7906-10G), 2 mM EDTA (Thermo Fisher, 15575020)) 
with 20 µl CD45 MicroBeads (Miltenyi Biotech, 130-045-801) and incu-
bated for 15 min at 4 °C. Cells were washed with 2 ml MACS buffer and 
centrifuged as above and resuspended in 500 µl MACS buffer. Cells 
were passed through a pre-wetted MS column (Miltenyi Biotech, 130-
042-201) on a QuadroMACS Magnetic Cell Separator (Miltenyi Biotech) 
followed by four rounds of 500 µl of MACS buffer. Flow-through was col-
lected as the CD45− fraction. The column was removed from the magnet 
and the CD45+ fraction was eluted with 1 ml of MACS buffer. CD45− and 
CD45+ fractions were centrifuged as above and resuspended in 0.5–1 ml 
of 0.04% (w/v) BSA in D-PBS. Cell count and viability was determined 
using a NucleoCounter NC-200 and Via1-Cassette (ChemoMetec) or 
haemocytometer and resuspended in 0.04% (w/v) BSA in D-PBS. Fetal 
CD45+ and CD45− fractions were combined at a 1:1 ratio.
Organoid culture
Intestinal organoids from paediatric patients were cultured in Matrigel 
(Corning). During organoid culture, the medium was replaced every 
48–72 h. Organoids were passaged using mechanical disruption with a 
P1000 pipette and re-seeded in fresh growth-factor-reduced Matrigel 
(Corning). When comparing culture media, multiple wells were seeded 
from a single dissociated sample. The organoids were then allowed to 
grow for 5 days followed by 24 h treatment with recombinant human 
protein TNF (H8916, Sigma Aldrich) at 40 ng ml−1 or IFNγ (PHC4031, Life 
Technologies) at 20 ng ml−1. Organoids were in vitro differentiated for 
4 days by culturing in a differentiation medium49 and then collected 
for RNA extraction. Bright-field images were taken using an EVOS FL 
system (Life Technologies).
Processing for single-cell sequencing analysis was performed by remov-
ing the organoids from Matrigel at passage 3–4 using incubation with Cell 
Recovery Solution at 4 °C for 20 min, pelleting the cells, and re-suspending 
in TrypLE enzyme solution (Thermo Fisher) for incubation at 37 °C for 
10 min. Cells were pelleted again and re-suspended in DMEM/F12.
RNA extraction, reverse transcription and quantitative PCR
Total RNA was extracted with the GenElute Mammalian Total RNA 
Miniprep kit (Sigma) and 1 µg of RNA was reverse-transcribed using 
the QuantiTect Reverse Transcription Kit (Qiagen). Complementary 
DNA corresponding to 5 ng RNA was used for real-time PCR per-
formed by QuantiFast SYBR Green PCR Master Mix (Qiagen) on the 
7500 Fast real-time PCR system, 7500 software v.2.0.6 (Applied Bio-
sciences by Thermo Fisher Scientific). Primers for the specific target 
amplification were: FCGR2A fwd 5ʹ-CCATCCCACAAGCAAACCACAG-3ʹ 
and rev 5ʹ-AGCAGTCGCAATGACCACAG-3ʹ; FCGR2B fwd 5ʹ-CCATCCC 
ACAAGCAAACCACAG-3ʹ and rev 5ʹ-ACAGCAATCCCAGTGACCACAG-3’; 
PLCG2 fwd 5ʹ-AACCCATCTGACCCTCCTCTTG-3ʹ and rev 5ʹ-AGACTGCTGTT 
CCCTGTGTTCC-3ʹ; POU2F3 fwd 5ʹ-TTCAGCCAGACCACCATCTCAC-3ʹ 
and rev 5ʹ-GGACTCTGCATCATTCAGCCAC-3ʹ; MUC2 fwd 5ʹ-GATTCGA 
AGTGAAGAGCAAG-3ʹ and rev 5ʹ-CACTTGGAGGAATAAACTGG-3ʹ; LGR5 
fwd 5ʹ-CTCCCAGGTCTGGTGTGTTG-3ʹ and rev 5ʹ-GAGGTCTAGGTAGG 
AGGTGAAG-3ʹ. Relative quantifications were normalized against 
GAPDH and calculated applying the ΔΔCt method.
Statistical analysis was performed using GraphPadPrism 7 software 
(GraphPad Software) by multiple t-test analysis.
10x Genomics Chromium GEX library preparation and 
sequencing
MACS-enriched and total cell fractions were loaded for droplet-based 
scRNA-seq according to the manufacturer’s protocol for the Chro-
mium Single Cell 5′ gene expression v.2 (10x Genomics) to obtain 
8,000–10,000 cells per reaction. Library preparation was carried out 
according to the manufacturer’s protocol. Pools of 16 libraries were 
sequenced across both lanes of an Illumina NovaSeq 6000 S2 flow cell 
with 50 bp paired-end reads.
Intestinal organoids were prepared using Chromium Single Cell 3′ 
gene expression v.2 (10x Genomics) to obtain 8,000 cells per reaction. 
Intestinal organoid cDNA libraries were sequenced on a single lane of 
an Illumina HiSeq 4000 with 50 bp paired-end reads.
V(D)J sample preparation
10x Genomics V(D)J libraries were generated from the 5′ 10x Genom-
ics Chromium complementary DNA (cDNA) libraries as detailed in 
the manufacturer’s protocol. B cell receptor (BCR) and T cell recep-
tor (TCR) libraries for relevant samples were pooled and sequenced 
on a single lane of an Illumina HiSeq 4000 with 150 bp paired-end 
reads.
Plate-based Smart-seq2
Plate-based scRNA-seq was performed with the NEBNext Single Cell/
Low Input RNA Library Prep Kit for Illumina (E6420L; New England 
Biolabs). Total cell fractions from dissociated gut sections of donors 
BRC2033–2034, F67, F72, F78 were snap-frozen in 10% (v/v) DMSO 
in 90% (v/v) BSA. Cells were thawed rapidly in a 37 °C water bath and 
diluted slowly with a pre-warmed FACS buffer (2% (v/v) FBS in D-PBS). 
Cells were pelleted by centrifugation for 5 min at 300g, washed with 
300 µl of D-PBS and pelleted as before. Cells were resuspended in 
100 µl of Zombie Aqua Fixable Viability Kit (1:200 dilution; 423101) 
and incubated at room temperature for 15 min. Cells were washed 
with 2 ml of FACS buffer followed by 300 µl of FACS buffer and resus-
pended in a total of 100 µl of Brilliant Violet 650 mouse anti-human 
CD45 (dilution 1:200; BioLegend, 304043), Alexa Fluor 700 mouse 
anti-human CD4 (dilution 1:200; BioLegend, 300526) and APC-H7 
mouse anti-human CD19 (dilution 1:200; BD Biosciences, 560727) 
and incubated for 20 min in the dark at room temperature. Cells were 
washed twice with 300 µl of FACS buffer. Single, live, CD45+ cells were 
sorted by fluorescence-activated cell sorting (FACS) into wells of a 
384-well plate (0030128508; Eppendorf) containing 2 µl of 1× NEB Next 
Cell Lysis Buffer (New England Biolabs). FACS sorting was performed 
with a BD Influx sorter (BD Biosciences) with the indexing setting 
enabled. Plates were sealed and spun at 100g for 1 min then immedi-
ately frozen on dry ice and stored at −80 °C. cDNA and sequencing 
library generation was performed in an automated manner on the 
Bravo NGS Workstation (Agilent Technologies)4. The purified pool 
was quantified on an Agilent Bioanalyzer (Agilent Technologies) and 
sequenced on one lane of an Illumina HiSeq 4000. Raw reads were 
aligned to the human transcriptome v.GRCh38-3.0.0 using STAR 
aligner (v.2.5.1b).
Pre-processing of 10x Genomics scRNA-seq data
10x Genomics scRNA-seq gene expression raw sequencing data were 
processed using the CellRanger software v.3.0.0–v.3.0.2 and the 10X 
human transcriptome GRCh38-3.0.0 as the reference. The 10x Genom-
ics V(D)J Ig heavy and light chains were processed using cellranger vdj 
v.3.1.0 and the reference cellranger-vdj-GRCh38-alts-ensembl-3.1.0 
with default settings.
scRNA-seq quality control and processing of 10x sequencing 
data
Pandas (v.1.1.2), NumPy (v.0.25.2), Anndata (v.0.6.19), ScanPy (v.1.4) 
and Python (v.3) were used to pool single-cell counts and for down-
stream analyses. Single-cell transcript counts for fetal and adult sam-
ples were handled separately to control for anticipated differences in 
cell expression and sample quality. For each run, we apply the SoupX 
algorithm50 with default parameters and function adjustCounts() to 
remove ambient mRNA from the count matrix. Cells for each dataset 
were filtered for more than 500 genes and less than 50% mitochondrial 
reads, and genes were filtered for expression in more than 3 cells. 
A Scrublet (v.0.2.1) score cut-off of 0.25 was applied to assist with dou-
blet exclusion. Additional doublet exclusion was performed through-
out downstream processing based on unexpected co-expression of 
canonical markers such as CD3D (component of the TCR) and EpCAM. 
Gene expression for each cell was normalized and log-transformed. 
Cell cycle score was calculated using the expression of 97 cell cycle 
genes listed in ref. 51. Cell cycle genes were then removed for initial 
clustering. Cell cycle score, the percentage of mitochondrial reads 
and unique molecular identifiers (UMIs) were regressed before scal-
ing the data.
Cell-type annotation
Batch correction of fetal and adult datasets was performed with 
bbknn (v.1.3.9, neighbours=2-3, metric=‘euclidean’, n_pcs=30-50, 
batch_key=‘donor_id’ or ‘batch’). Dimensionality reduction and Leiden 
clustering (resolution 0.3–1.5) was carried out and cell lineages were 
annotated on the basis of algorithmically defined marker gene expres-
sion for each cluster (sc.tl.rank_genes_groups, method=‘wilcoxon’). 
Cell lineages were then subclustered and batch correction and Lei-
den clustering were repeated for annotation of cell types and states. 
Annotated fetal and adult datasets were then merged and annotations 
adjusted for concordance. A brief description of cell-type annotation 
for each lineage is provided below.
Epithelial lineage cells (EPCAM-positive) shared between fetal, paedi-
atric and adult datasets were stem cells (LGR5, ASCL2, SMOC2, RGMB, 
OLFM4), Paneth (DEFA5, DEFA6, REG3A), transit-amplifying (TA; MKI67, 
TOP2A, PCNA), goblet cells (CLCA1, SPDEF, FCGBP, ZG16, MUC2), BEST4 
enterocytes (BEST4, OTOP2, CA7), enterocytes (RBP2, ANPEP, FABP2) 
and colonocytes (CA2, SLC26A2, FABP1), enteroendocrine cells (CHGA, 
CHGB, NEUROD1), Microfold cells (SPIB, CCL20, GP2), Tuft cells (POU2F3, 
LRMP (also known as IRAG2), TRPM5), BEST2 goblet cells were observed 
in adult colonic samples (Extended Data Fig. 5). Amongst the genes 
enriched in BEST2 goblet cells were Kallikreins KLK15 and KLK3, as well 
as protease inhibitors WFDC2 and WFDC3. Among fetal epithelial cells, 
43 large intestinal goblet cells expressed BEST2. Fetal BEST2-expressing 
cells clustered together with small intestinal goblet cells, possibly due 
to the small number of these cells present in the data. Enteroendocrine 
cells were further sub-clustered and annotated based on key hormones 
expressed (M/X cells (MLN/GHRL), D cells (SST), β cells (INS, possibly 
from developing pancreatic bud), L cells (GCG), N cells (NTS), K cells 
(GIP), I cells (CCK) and enterochromaffin cells (TPH1) either expressing 
neuropeptide W (NPW) or TAC1).
Fetal-specific subsets included proximal progenitors (FGG, BEX5) as 
described in refs. 1–3,52, distal progenitors enriched for colon genes (CKB, 
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AKAP7, GPC3) and CLDN10 cells that are possibly pancreatic progeni-
tors based on expression of DLK1, PDX1, RBPJ, CPA1 and SOX953. This 
population also highly expressed CLU, a marker for intestinal revival 
stem cells that has previously been described54.
 
Endothelial lineage cells (PECAM1, CDH5) were subdivided into arte-
rial (GJA4, HEY1, HEY2, EFNB2), venous (ACKR1, VWF) and lymphatic 
endothelium (PROX1, LYVE1, CCL21). Arterial and venous cells from 
fetal and adult donors formed separate clusters and differed in gene 
expression, possibly reflecting fetal cell immaturity. Among age-shared 
arterial genes were GJA5, SEMA3G, HEY1, HEY2 and age-shared venous 
genes were ACKR1, ADGRG6, CPE, APLNR. Capillary clusters were defined 
based on expression of RGCC and VWA1. Arterial capillaries specifically 
expressed CA4 and FCN3.
Lymphatic endothelium further separated into six clusters, including 
LEC1 (ACKR4, OTC), resembling cells lining the subcapsular sinus ceiling 
in the human lymph nodes;31 LEC2 (GP1BA, UBD, ANO9, FIBIN, PAPLN) 
and only LEC expressing MADCAM1 and reassembled LECs lining sub-
capsular sinus floor in human lymph nodes31. We further define LEC3 
(ADGRG3hi) present mostly in the paediatric and adult intestinal regions, 
and LEC4 (SATB2hi, PTX3hi, CXADRhi) specific to developing gut (Extended 
Data Fig. 7c) that may represent differentiated and immature lymphatic 
vessels, respectively. LEC5 (CLDN11, DEGS2, SBSPON, ANGPT2hi, GJA4hi) 
reassembled collecting lymphatic valves in lymph nodes31.
Neural lineage cells were defined on the basis of observations in mouse 
embryos55. Neuronal branches were named branch A or B on the basis 
of expression of ETV1 or BNC2, respectively. Subpopulations of the 
branches were named A1–A4 and B1–B3 and combinatorial gene mark-
ers are provided in Fig. 3a, b. Branch A1 was functionally named inhibi-
tory motor neurons (iMN) based on expression of GAL, NOS1 and VIP; 
branch A2 was a mixed IPAN/IN population based on NTNG1 and NXPH2. 
Branch A3 was a second subset of IPAN/IN equivalent to adult PIN3 and 
PSN3;22 Branch A4 were annotated as interneurons (IN) based on NEU-
ROD6 expression22. Branch B1 were annotated as immature excitatory 
motor neurons (eMN) based on NXPH4 and NDUFA4L2;22 branch B2 was 
a second cluster of eMN based on expression of BNC2 and PENK;22,55 
branch B3 (IPAN) was assigned the IPAN label based on DLX3, ANO2, 
NOG and NTRK3. Branch B3 also showed the expression of CALB2 and 
SST described in the human IPAN A population23.
All terminal glial cells expressed high levels of ENCC progenitor/
terminal glial marker genes including FOXD3, MPZ, CDH19, PLP1, SOX10, 
S100B and ERBB3, but lacked RET. Three types of enteric glia (S100B, 
CRYAB, MPZ) were observed: glia 1 (DHH, RXRG, NTRK2, MBP), glia 2 (ELN, 
TFAP2A, SOX8, BMP8B), glia 3 (BCAN, APOE, CALCA, HES5, FRZB) and a 
subset of differentiating glia (COL20A1) were present at 12–17 PCW 
(Fig. 3b). Differentiating glia (COL20A1) cluster annotation was based 
on expression of glial markers, positioning in between differentiating 
subsets and scVelo results.
Mesenchymal lineage cells included previously described mesoder-
mal populations mesoderm 1 (HAND1, HAND2, PITX2) and mesoderm 
2 (ZEB2);1 stromal 1 (ADAMDEC1) subset either highly expressing ADAM28 
or CCL11, CCL8, CCL13; stromal 2 (PDGFRA, BMP4) either enriched for 
F3, NPY or CH25H, MMP1 expression; stromal 3 (C7) expressing KCNN3, 
LRRC3B or C3, CLEC3B, SEMA3E. We also observe the stromal 4 popu-
lation (MMP1, MMP3, PDPN, COL7A1, CHI3L1) most recently described 
in the fetal gut3. In addition, we observe populations consistent with 
lymph-node immune-organizing fibroblasts including T reticular cells 
(CCL19, GREM1hi, TNFSF13B)32, follicular dendritic cells (CXCL13, CR1, 
CR2)32, a population of FMO2 stromal cells (LMO3, RASD1, PODNhi) found 
in the mLN samples that may represent adipose stromal cell population 
based on the expression of FOXO1, KLF15, ZBTB16, LMO3, HSD11B156,57. 
Myofibroblasts were identified on the basis of expression of actin (ACTA2) 
and transgelin (TAGLN), fibroblast characteristic decorin (DCN), but 
lacked smooth muscle marker desmin (DES). Myofibroblast popula-
tions further differed in the expression of HHIP, NPNT, SYT10 or RSPO2, 
SYT1, PTGER1. Smooth muscle cells were annotated on the basis of high 
expression of DES, calponin (CNN1)58 and actin/myosin chain expression 
(ACTA2, MYH11) and subsets were further characterized following the 
annotation in ref. 3. Interstitial cells of Cajal (ICC) were identified on the 
basis of expression of KIT, ANO1 and ETV132,59. Other ICC genes included 
DLK1, CDH8, CDH10 and PRKCQ. Cycling stromal cells were defined based 
on expression of MKI67, TOP2A, CDK1 and other cell cycle genes. Fetal 
mLTo cells were defined as discussed in the text. Additionally, mLTo cells 
were high for UBD, CLSTN3, SLC22A3, TNFSF11 and APLNR expression.
Pericytes were identified on the basis of expression of NOTCH3, MCAM 
(CD146) and RGS5. Immature pericytes were annotated based on high 
expression of PDGFRB, CSPG4 (encoding NG2)58 and was marked by 
high NDUFA4L2 expression. We further annotate contractile pericytes 
(ACTA2hi) that were specifically marked by expression of PLN, RERGL, 
KCNA5, KCNAB1, NRIP2. Angiogenic pericytes were annotated based 
on high expression of PRRX1 and PROCR among pericyte populations 
(also expressed in stromal cells) as described in ref. 3, and also more 
specifically marked by ENPEP, ABCC8, COL25A1 and TEX41. We also 
observe a population of pericytes marked by CD3660 (named ‘Pericyte’).
Mesothelial cells were defined on the basis of KRT19, LRRN4 and 
UPK3B expression, as observed previously1,61, and additionally observe 
the expression of TNNT1, RASSF7 and KLK11 in these cells. Mature peri-
cytes captured in adult tissues highly expressed PRG4, MT1F, MT1G, 
CP4BPA, and HAS1. In addition, we observe a population of mesothelial 
cells expressing RGS5, TMEM235 and SERPINE3.
B lineage cells were defined as the cluster having positive expression 
of MS4A1 (encodes CD20) and CD19. Among fetal B cells, common 
lymphoid progenitor (CLP) cells were classified on the basis of minimal 
expression of the lineage markers and specific expression of CD34, 
SPINK2 and FLT3. Pro-B cells had specific expression of DNTT (TdT), 
recombination-activating genes (RAG) 1 and 2, high expression of B 
lymphocyte antigen receptor CD79B, V-set pre-B cell surrogate light 
chains (VPREB1, VPREB3) and expression of immunoglobulin-lambda 
chain IGLL1. Pre-B cells specifically expressed CD38 and had higher 
expression of CD19 than pro-B cells. Immature B cells had the highest 
expression of MS4A1 among B lineage cells and expression of immu-
noglobulin heavy chains M and D. Adult B lineage cells had distinct 
clusters of naive B cells (Fc fragment of IgM receptor- FCMR), memory 
B cells (SELL (encodes CD62L)) and a population of memory B cells that 
specifically expressed transmembrane immunoregulatory molecule 
FCRL4 (encodes protein also known as FcRH4) that has been suggested 
to be tissue-restricted62 Class switch IgA and IgG plasma cells showed 
expression of the syndecan, SDC1, and immunoglobulin heavy chains 
A and G, respectively. Cycling B cells were characterized by specific 
expression of MKI67 (encodes Ki67) and genes involved in DNA replica-
tion, HMGB2, TUBA1B and UBE2C.
T lineage cells were determined as the cluster of fetal, paediatric and 
adult cells with expression of T cell receptor component CD3D and 
subpopulations were annotated as previously described4. CD4 T cells 
had expression of CD4, but not CD8A, and vice versa for CD8 T cells. 
For each of these T cell groups, a population of paediatric/adult SELL 
(encodes CD62L) naive/central memory cells and CD69 activated cells 
was assigned. ‘Activated T’ are fetal cells that have productive TCRαβ 
chains as determined by paired V(D)J sequencing. In addition, among 
postnatal CD4 T cells are CXCR3,IFNG TH1 and RORA
hi,IL22, CD20 TH17 
cells. Paediatric CD CD4 T cells labelled as TH1 and TH17 showed addi-
tional co-expression of IL22 and IL26, matching previously reported 
expression of these molecules in dysfunctional CD8 T cells in ulcera-
tive colitis8. T regulatory cells were defined by FOXP3, CTLA4, TIGIT 
expression and T follicular helper cells expressed CXCR5 and PDCD1. 
Two subsets of CD8 T memory cells were observed: CD8 Tmem and 
CX3CR1-expressing CD8 Tmem cells that both expressed FGFBP2, S1PR5, 
FCGR3A and TGFBR3.
Adult gdT subsets differentially expressed gamma and delta variable 
chain genes. Paediatric gdT (TRDC) cells did not have TCR sequenc-
ing data and did not express specific variable chains (Extended Data 
Fig. 2a). Specific expression of TRGV2, TGVG4 and TRVG5/TRVG7, which 
each encode a variable chain of the gamma TCR chain, further defined 
subpopulations respectively. We also observe a population of TRDV2/
TRGV9 gdT cells63 in the fetal gut. NK T cells expressed CD3D as well as 
NK genes GZMA, NKG7 and PRF1. MAIT cells expressed TRAV1, TRAV2 
and SLC4A10. ILC2 expressed PTGDR2, HPGDS, IL1RL1 and KRT164 and 
were found in the fetal samples.
NK cells were defined on the basis of EOMES, PRF1, NKG7 and KIR 
receptor expression. Adult ILC3s were defined based on the expres-
sion of RORC, IL1R1, IL23R, KIT64 and further expressed TNFS4 and 
PCDH9. ILCP were defined as Lin− IL7R (encodes CD127), KIT (CD117), 
RORC (RORγ) cells that further express CCR6, NRP1, but not NCR2 
(encodes NKp44), as described in the liver65. ILCPs also highly expressed 
chemokine receptors CXCR5 and CCR7, cell adhesion molecule encoded 
by SCN1B66 and serine protease encoded by HPN.
LTi-like NCR+ ILC3 cells had highest expression of TNFRSF11A (RANK) 
and its ligand TNFSF11 (RANKL), as well as NCR1 (NKp46) and NCR2 
(NKp44), whereas LTi-like NCR- ILC3s lacked NCR2 (NKp44) and 
expressed IL17A, ITGAE and CCR9, and NK-associated genes including 
NKG7, PRF1 and GZMA, consistent with NCR− ILC3 cells described in 
mice67. We observed the expression of IL22 in the adult compared to 
fetal NRC2+ ILC3s, suggesting that fetal gut ILC3 represents an immature 
ILC3 counterpart. Reassuringly, the LTi-like subtypes were identifiable 
in full-length scRNA-seq data from fetal ileum (Extended Data Fig. 11).
Myeloid lineage cells further sub-clustered to classical monocytes 
(FCN1, S100A4, S100A6), dendritic cells, macrophage, mast cells 
(GATA2, CPA3, HPGDS) and megakaryocytes (GP9, LCN2). Among den-
dritic cells (DCs) we observed cDC1 (CLEC9A) and cDC2 (CLEC10A), 
lymphoid DCs (LAMP3) and plasmacytoid DCs (pDCs; CLEC4C, JCHAIN). 
Among macrophage populations, we observe a subset of classical mac-
rophages (CD163, C1QB, C1QC), LYVE1+ macrophages (RNASE1, SPP1) that 
have been previously observed in around heart vessels68 and lung69 and 
inflammatory macrophages (MMP9);10 we also observe a fetal-specific 
population of mono-neutrophil progenitors (MPO, AZU1, ELANE) pre-
viously described in human fetal liver30 and CLC mast cells that could 
represent immature fetal states.
Cell-type scoring
For MHCII scoring of B cells we use the following genes: SECTM1, 
CD320, CD3EAP (also known as POLR1G) CD177, CD74, CIITA, RELB, TAP2, 
HLA-DRA, HLA-DRB5, HLA-DRB1, HLA-DQA1, HLA-DQB1, HLA-DQB1-AS1, 
HLA-DQA2, HLA-DQB2, HLA-DOB, HLA-DMB, HLA-DMA, HLA-DOA, 
HLA-DPA1, HLA-DPB1. Glial or neuronal cell signature score was calcu-
lated using the curated gene sets from ref. 70 (glia: ERBB3, PLP1, COL18A1, 
SOX10, GAS7, FABP7, NID1, QKI, SPARC, MEST, WWTR1, GPM6B, RASA3, 
FLRT1, ITPRIPL1, ITGA4, POSTN, PDPN, NRCAM, TSPAN18, RGCC, LAMA4, 
PTPRZ1, HMGA2, TGFB2, ITGA6, SOX5, MTAP, HEYL, GPR17, TTYH1; neu-
ronal: ELAVL3, ELAVL4, TUBB2B, PHOX2B, RET, CHRNA3). NF-kB sig-
nalling pathway score was calculated using genes from http://www.
gsea-msigdb.org/gsea/msigdb/genesets.jsp (NFKB2, BIRC3, TNFAIP2, 
TNIP1, NOTCH2, TMEM173 (also known as STING1) TIFA, PRDX4, CAMK4, 
BCL3, CHUK, IKBKB, IKBKE, NFKB1, NFKB2, NFKBIA, NFKBIB, NFKBIE, REL, 
RELA, RELB). The scoring was done using sc.tl.score_genes() function 
with default parameters to calculate the average expression of selected 
genes substrated with the average expression of reference genes.
Intestinal organoid analysis
Single-cell count matrices from three organoid growth conditions 
were combined together using Pandas (v.1.1.2) and NumPy (v.0.25.2) 
packages. Cells with fewer than 8,000 genes and with less than 20% 
mitochondrial reads were included in the analysis. Genes with expres-
sion in fewer than 3 cells were also excluded. For PLCG2 expression 
comparison we use normalized (sc.pp.normalize_per_cell) and 
log-transformed (sc.pp.log1p) counts. The data were plotted using 
Seaborn package bar plot and swarmplot functions (v.0.11.0).
Pre-processing and analysis of Smart-seq2 sequencing data
Cells with more than 6,000 genes and greater than 25% mitochondrial 
reads were excluded, before regression of ‘n_counts’, ‘percent_mito’ and 
‘G2M_score’. Cells positive for PTPRC expression (logTPM+1 > =0.2) were 
taken forward for downstream analysis. T cell receptor sequences gen-
erated using the Smart-seq2 scRNA-seq protocol were reconstructed 
using the TraCeR software (https://hub.docker.com/r/teichlab/tracer/) 
as described previously71.
Differential cell-state abundance analysis for BEST4 cells
To identify region-specific subpopulations, we performed composi-
tional analysis between BEST4 enterocytes from small and large intes-
tine tissue, using a tool for differential abundance testing on k-nearest 
neighbour (KNN) graph neighbourhoods, implemented in the R pack-
age miloR (v.0.99.8) https://github.com/MarioniLab/miloR14.
In brief, we performed PCA dimensionality reduction and KNN graph 
embedding on the BEST4 enterocytes. We define a neighbourhood as 
the group of cells that are connected to a sampled cell by an edge in 
the KNN graph. Cells are sampled for neighbourhood construction 
using the algorithm proposed previously72. For each neighbourhood 
we then perform hypothesis testing between conditions to identify 
differentially abundant cell states whilst controlling the FDR across 
the graph neighbourhoods.
We test for differences in abundance between the cells from small 
and large intestine tissue in adult samples and fetal samples. To identify 
markers of small-intestine-specific and large-intestine-specific sub-
populations, we performed differential gene expression (DGE) analysis 
between adult cells in neighbourhoods enriched for small intestine cells 
and in neighbourhoods enriched for large intestine cells (10% FDR for 
the differential abundance test). The DGE test was performed using 
a linear model implemented in the package limma73 (v.3.46.0), using 
10% FDR, and aggregating expression profiles by sample(implemented 
in the function findNhoodGroupMarkers of the miloR package, with 
option aggregateSamples = TRUE). Gene Ontology enrichment analysis 
was performed using the R package clusterProfiler (v.3.18.1).
RNA velocity and diffusion map pseudotime analyses
For neural cell trajectory analysis we use scVelo 0.21 package implemen-
tation in Scanpy 1.5.174. The data were sub-clustered on fetal neural cells 
and pre-processed using functions for detection of minimum number 
of counts, filtering and normalization using scv.pp.filter_and_nor-
malize and followed by scv.pp.moments function. The gene-specific 
velocities were obtained using scv.tl.velocity(mode = ‘stochastic’) 
and scv.tl.velocity_graph() by fitting a ratio between unspliced and 
spliced mRNA abundances. The gene specific velocities were visual-
ized using scv.pl.velocity_graph() or scv.pl.velocity_embedding_grid() 
functions. To visualize genes that change along the pseudotime we use 
sc.pl.paga_path() function with pseudotime set to monocle3 pseu-
dotime. This function required calculation of PAGA parameters and 
dpt_pseudotime with functions as follows: sc.tl.paga(), sc.pl.paga(), 
sc.tl.draw_graph(init_pos = ‘paga’), sc.tl.dpt()75.
BCR analysis
Single-cell BCR analyses were performed as described previously76. In 
brief, poor quality or incomplete V(D)J contig sequences were discarded 
and all IgH sequences for each donor were combined together. IgH 
sequences were annotated with IgBLAST77 before isotype reassign-
ment using AssignGenes.py (pRESTO78). Ambiguous V gene calls were 
Article
corrected using TIgGER v.03.179 before identifying clonally related 
sequences with DefineClones.py (ChangeO v.0.4.579) using a threshold 
of 0.2 for nearest-neighbour distances. The germline IgH sequence for 
each clonal family was determined using CreateGermlines.py (ChangeO 
v.0.4.5) followed by using observedMutations (Shazam v.0.1.1179) to 
calculate somatic hypermutation frequencies for individual sequences. 
Finally, for integration with the single-cell gene expression object, the 
number of high quality and annotated contigs per Ig chain (IgH, IgK, 
IgL) was determined for each cell barcode. If multiple unique sequences 
for a given chain were detected, that cell was annotated as ‘Multi’ and 
not considered in further analysis. BCR metadata was combined with 
the scRNA object for downstream analysis and comparison of different 
B cell populations.
Cell–cell communication analysis
To infer cell–cell communication and screen for ligands and receptors 
involved we applied the CellPhoneDB v.2.0 Python package80,81 on the 
normalized raw counts and fine cell-type annotations from the second 
trimester intestinal samples (12–17 PCW). We use default parameters 
and set subsetting to 5,000 cells. To identify the most relevant interac-
tions, we subset specific interactions on the basis of the ligand/recep-
tor expression in more than 10% of cells within a cluster and where 
the log2 mean expression of the pair is greater than 0. The selected 
interactions were plotted as expression of both ligand and receptor 
in relevant cell types.
Gene expression linked to enteric nervous system disease
HSCR-related genes were curated from The Human Phenotype 
Ontology website (https://hpo.jax.org/app/, Aganglionic megacolon 
HP:0002251) and ref. 25. We selected genes with expression greater 
than or equal to 0.1 in neural lineage single cells and calculated mean 
expression per cluster and organ. Expression was visualized using 
seaborn.clustermap() function (v.0.11.0).
Cell-type composition analysis using metadata
The number of cells for each sample (n = 159 samples in total with com-
plete metadata) and coarse-grain cell type (9 different cell types in total) 
combination was modelled with a generalized linear mixed model with 
a Poisson outcome. The five clinical factors (age group, donor, biopsy, 
disease and gender) and the three technical factors (fraction, enzyme 
and 10x kit) were fitted as random effects to overcome the collinearity 
among the factors. The effect of each clinical or technical factor on 
cell-type composition was estimated by the interaction term with the 
cell type. The ‘glmer’ function in the lme4 package implemented on R 
was used to fit the model. The standard error of the standard deviation 
parameter for each factor was estimated using the numDeriv package. 
The effect size of each level of a clinical or technical factor was obtained 
by the posterior mean of the corresponding random effect coefficient 
and the local true sign rate (LTSR) was calculated from the posterior 
distribution. See Supplementary Note Section 1 for more details.
Cell-type enrichment analysis for IBD-GWAS genes
Inflammatory bowel disease genome-wide association study (IBD 
GWAS) summary statistics of Crohn’s disease and ulcerative colitis were 
obtained from the International Inflammatory Bowel Disease Genet-
ics Consortium (IIBDGC) (https://www.ibdgenetics.org/). The GWAS 
enrichment analysis of 103 annotated gut cell types for Crohn’s disease 
and ulcerative colitis was performed using a fGWAS approach82,83, often 
used for fine-mapping and enrichment analysis of various functional 
annotations for molecular quantitative trait and GWAS loci. The asso-
ciation statistics (log odds ratios and standard errors) were converted 
into the approximate Bayes factors using the Wakefield approach84. 
A cis-regulatory region of 1 Mb centred at the transcription start site 
(TSS) was defined for each gene (Ensembl GRCh37 Release 101). The 
Bayes factors of variants existing in each cis region were weighted 
and averaged by the prior probability (an exponential function of TSS 
proximity) estimated from the distance distribution of regulatory 
interactions85. The likelihood of an fGWAS model was given by the ave 
raged Bayes factors across all genome-wide genes multiplied by the 
feature-level prior probability obtained from a linear combination of 
cell-type-specific expression and the averaged expression across all cell 
types as a baseline expression. The enrichment of each cell type was 
estimated as the maximum likelihood estimator of the effect size for 
the cell-type-specific expression. The code of the hierarchical model 
(https://github.com/natsuhiko/PHM) was utilized for the enrichment 
analysis. The detailed model derivation is demonstrated in Supple-
mentary Note section 2.
Visium spatial transcriptomics sample preparation
10x Genomics Visium protocol was applied on optimal cutting tempera-
ture medium (OCT)-embedded fresh frozen samples. All tissues were 
sectioned using the Leica CX3050S cryostat and were cut at 10 µm. The 
samples were selected on the basis of morphology, orientation (based 
on H&E) and RNA integrity number that was obtained using Agilent2100 
Bioanalyzer. Tissue optimization was performed to obtain permeabili-
zation time for fetal tissue (12 min) and after optimization the Visium 
spatial gene expression protocol from 10X Genomics was performed 
using Library Preparation slide and following the manufacturer’s pro-
tocol. After transcript capture, Visium Library Preparation Protocol 
from 10x Genomics was performed. All images for this process were 
scanned at 40× on Hamamatsu NanoZoomer S60. Eight cDNA libraries 
were diluted and pooled to a final concentration of 2.25 nM (200 µl 
volume) and sequenced on 2× SP flow cells of Illumina NovaSeq 6000.
10x Genomics Visium data processing
10x Genomics Visium spatial sequencing samples were aligned to 
the human transcriptome GRCh38-3.0.0 reference (consistently with 
single-cell RNA-seq samples) using 10x Genomics SpaceRanger v.1.2.1 
and exonic reads were used to produce mRNA count matrices for each 
sample. 10x Genomics SpaceRanger was also used to align paired his-
tology images with mRNA capture spot positions in the Visium slide. 
The paired image was used to determine the average number of nuclei 
per Visium location in the tissue and used as a hyperparameter in the 
spatial mapping of cell types.
Spatial mapping of cell types with cell2location
To spatially map developing gut cell types in situ, 10x Genomics Visium 
mRNA count matrices were integrated with scRNA-seq data using the 
cell2location method as described in detail previously34. In brief, the 
cell2location model estimates the abundance of each cell population in 
each location by decomposing mRNA counts in 10x Genomics Visium 
data using the transcriptional signatures of reference cell types. Ref-
erence signatures of 65 cell populations (neuronal and mesenchymal 
subtypes were grouped together where relevant to simplify interpreta-
tion of spatial mapping) from the 12–17 PCW small intestine samples 
were estimated using a negative binomial regression model provided 
in the cell2ocation package. We provide spatial cell abundance maps of 
all 65 cell subsets on GitHub (https://github.com/vitkl/fetal_gut_map-
ping/) and the distribution of all 65 cell subsets across tissue zones in 
Extended Data Fig. 9a–c.
Untransformed and unnormalized mRNA counts were used as 
input to both the regression model for estimating signatures (filtered 
to 13,904 genes and 124,049 cells) and the cell2location model for 
estimating spatial abundance of cell populations (filtered to 13,904 
genes shared with scRNA-seq, 4,645 locations, 3 experiments analysed 
jointly).
Cell2location was used with the following settings (all other settings 
set to default values): training iterations: 40,000; cells per location 
N̂ = 12, estimated on the basis of comparison with histology image 
paired with 10x Genomics Visium; cell types per location Â = 8, assum-
ing that most cells in a given location are of a different type; co-located 
cell type groups per location Ŷ = 4.
To identify tissue zones and groups of cell types that belong to them 
(Extended Data Fig. 15c, dot plot), conventional non-negative matrix 
factorization (NMF) was applied to cell abundance estimated by cell-
2location. The NMF model was trained for a range of factors and tissue 
zones R = {8,…,35} and the decomposition into 17 factors was selected 
as a balance between segmenting relevant tissue zones (lymphoid 
structures, blood vessel types) and over-separating known zones into 
several distinct factors. NMF weight for each factor and cell type is 
shown in Extended Data Fig. 15c.
Cryosectioning, single-molecule fluorescence in situ 
hybridization and confocal imaging
Fetal gut tissue was embedded in OCT and frozen on an isopentane-dry 
ice slurry at −60 °C, and then cryosectioned onto SuperFrost Plus slides 
at a thickness of 10 µm. Before staining, tissue sections were post-fixed 
in 4% paraformaldehyde in PBS for 15 min at 4 °C, then dehydrated 
through a series of 50%, 70%, 100% and 100% ethanol, for 5 min each. 
Staining with the RNAscope Multiplex Fluorescent Reagent Kit v2 Assay 
(Advanced Cell Diagnostics, Bio-Techne) was automated using a Leica 
BOND RX, according to the manufacturers’ instructions. After manual 
pre-treatment, automated processing included epitope retrieval by 
protease digestion with Protease IV for 30 min prior to RNAscope probe 
hybridization and channel development with Opal 520, Opal 570, and 
Opal 650 dyes (Akoya Biosciences). Stained sections were imaged with a 
Perkin Elmer Opera Phenix High-Content Screening System, in confocal 
mode with 1 µm z-step size, using a 20× water-immersion objective (NA 
0.16, 0.299 µm per pixel). Channels: DAPI (excitation 375 nm, emission 
435–480 nm), Opal 520 (ex. 488 nm, em. 500–550 nm), Opal 570 (ex. 
561 nm, em. 570–630 nm), Opal 650 (ex. 640 nm, em. 650–760 nm). The 
fourth channel was developed using TSA-biotin (TSA Plus Biotin Kit, 
Perkin Elmer) and streptavidin-conjugated Atto 425 (Sigma-Aldrich).
Flow cytometry validation of Fcgr on mice tuft cells
C57BL/6 mice received either normal drinking water or 2% (w/v) 
36,000–50,000 MW dextran sodium sulfate (DSS) (MP Biomedicals) 
to induce colitis. For DSS treatment, mice received DSS water for 5 days 
followed by 14 days of normal drinking water, and then a final 5 days of 
2% (w/v) DSS prior to being culled.
The small intestines of mice were flushed of faecal content with 
ice-cold PBS, opened longitudinally, cut into 0.5-cm pieces, and 
washed by vortexing three times with PBS with 10 mM HEPES. Tissue 
was then incubated with an epithelial stripping solution (RPMI-1640 
with 2% (v/v) FCS, 10 mM HEPES, 1 mM DTT and 5 mM EDTA) at 37 °C 
for two intervals of 20 min to remove epithelial cells. The epithelial 
fraction was subsequently incubated at 37 °C for 10 min with dispase 
(0.3 U ml−1, Sigma-Aldrich) and passed through a 100-µm filter to 
obtain a single-cell suspension. Cells were blocked for 20 min at 4 °C 
with 0.5% (v/v) heat-inactivated mouse serum followed by extracel-
lular staining in PBS at 4 °C for 45 min with the following antibodies; 
EpCAM-FITC (1:400, G8.8, Invitrogen), CD45-Bv650 (1:200, 30-F11, 
BioLegend), CD11b-Bv421 (1:300, M1/70, BD Biosciences), Siglec-F-APC 
(1:200, 1RNM44N, Invitrogen), FcγRI-PE (1:200, X54-5/7.1, BioLeg-
end), FcγRIIB-PE (1:200, AT130-2, Invitrogen), FcγRII/RIII-PE-Cy7 
(1:200, 2.4G2, BD Biosciences), FcγRIV-PE (1:200, 9E9, BioLegend) 
and Rat IgG2b, κ isotype-PE-Cy7 (1:200, LOU/C, BD Biosciences). Cells 
were then stained with LIVE/DEAD Fixable Aqua Dead Cell Stain Kit 
(Thermo Fisher Scientific) for 20 min at room temperature, fixed 
with 2% PFA, and analysed on a CytoFLEX LX (Beckman Coulter) flow 
cytometer.
Reporting summary
Further information on research design is available in the Nature 
Research Reporting Summary linked to this paper.
Data availability
The expression data for fetal and adult regions is available on an inter-
active website: https://www.gutcellatlas.org/. Raw sequencing data 
are available at ArrayExpress (https://www.ebi.ac.uk/arrayexpress) 
with accession numbers E-MTAB-9543, E-MTAB-9536, E-MTAB-9532, 
E-MTAB-9533 and E-MTAB-10386. Previously published first trimester 
and paediatric data are available at ArrayExpress (E-MTAB-8901)1. For 
the purpose of Open Access, the authors have applied a CC BY public 
copyright licence to any Author Accepted Manuscript version arising 
from this submission. Source data are provided with this paper.
Code availability
Processed single-cell RNA sequencing objects are available for online 
visualization and download at https://www.gutcellatlas.org/. The code 
generated during this study is available at Github: https://github.com/
Teichlab/SpaceTimeGut, https://github.com/vitkl/fetal_gut_mapping/, 
https://github.com/natsuhiko/PHM.
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Extended Data Fig. 1 | See next page for caption.
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Extended Data Fig. 1 | Data quality control. a, Schematic showing tissue 
processing strategy for second trimester fetal, paediatric and adult scRNA-seq 
samples. After enzymatic dissociation, either total fraction was loaded onto a 
10x Genomics Chromium chip or CD45+/− cell fractions were separated using 
magnetic cell sorting (MACS) and both fractions were loaded on the 10x 
Genomics Chromium chip separately. Lymph nodes were processed without 
enrichment. Second trimester fetal and adult cell samples were processed 
using 5ʹ v2 10x Genomics Chromium kits (Methods). b, Pre-processing and 
quality control of single-cell RNA-seq data generated in this study and 
described previously1. In short, four datasets—namely first trimester fetal, 
second trimester fetal, paediatric healthy and Crohn’s disease, and adult—were 
pre-processed separately (including quality control, soupX analysis and 
scrublet doublet removal). Firstly, dimension reduction, clustering and 
annotation by cell lineage was performed on each dataset separately. Each cell 
lineage was sub-clustered and a fine-grained cell type and cell state annotation 
was performed based on marker gene expression. The four datasets were then 
merged together and each lineage was sub-clustered to unify cell type labels 
where appropriate. UMAP visualizations show the combined dataset coloured 
by sample age, enrichment fraction and donor name. c, UMAP visualization of 
cellular landscape of the human intestinal tract coloured by cellular lineage.  
d, Forest plot showing the relative importance (explained standard deviation) 
of each technical/biological factor on the cell type proportion. The 95% 
confidence intervals were computed from n = 1,431 data points (9 cell types × 
159 samples). See Method section for more details. e, Dot plot in which the fold 
change represents the enrichment (or depletion, low fold change in blue) of 
cells compared with baseline. The LTSR value represents statistical 
significance of the fold change estimate ranging from 0 to 1, where 1 represents 
a confident estimate. See Method section for more details. f, Bar plots with 
relative proportion of cell lineages in each 10x Genomics Chromium run 
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Extended Data Fig. 2 | Cell types defined in the study. a, Dot plot for expression of marker genes of cell types and states in each cell lineage in the scRNA-seq 
dataset. Relates to Supplementary Tables 3, 4.
Article
Extended Data Fig. 3 | Region variability in BEST4 enterocytes.  
a, Expression of CSTE (antibody: CAB032687, n = 3 biologically independent 
samples for each region) in gut histological sections from proteinatlas.org. 
Scale bar = 50 µm. b, UMAP visualization of BEST4 enterocytes in scRNA-seq 
dataset coloured by key marker BEST4/OTOP2 expression and region group 
(fetal and paediatric/adult). c, Volcano plot for differential abundance (DA) 
between cells from the small intestine and large intestine as in b. Each point 
represents a neighbourhood of BEST4 enterocytes (FDR: False Discovery Rate, 
logFC: log-Fold Change) for adult (red) and fetal samples (blue). The dotted line 
indicates the significance threshold of 10% FDR. d, Heat map showing the 
average neighbourhood expression of genes differentially expressed between 
DA neighbourhoods in adult BEST4 enterocytes (1,502 genes) as in c. 
Expression values for each gene are scaled between 0 and 1. Neighbourhoods 
are ranked by log-fold change in abundance between conditions. Positive 
log-fold change is small intestine neighbourhoods and negative is large 
intestine neighbourhoods. e, Expression of CFTR (antibody: CAB001951/
HPA021939, n = 3 biologically independent samples for each region) in small 
intestinal (top) and colonic (bottom) histological sections from Human Protein 
Atlas (proteinatlas.org). Scale bar = 50 µm. f, Immunohistochemistry staining of 
BEST4 (HPA058564) and CFTR (HPA021939) in small intestinal sections as in e.  
Black arrows point to cells with goblet cell morphology and red arrows point to 
cells expressing either BEST4 or CFTR. Scale bar = 20 µm.
Extended Data Fig. 4 | Function of BEST4 epithelial cells. a, b, Gene ontology terms from genes upregulated in BEST4 enterocytes from adult small (a) versus 
large (b) intestines as determined from Milo analysis13.
Article
Extended Data Fig. 5 | BEST2+ goblet cells. a, UMAP visualization of 
expression of MUC2 (indicating goblet cells) and BEST2 in paediatric/adult 
epithelial cells from scRNA-seq dataset. b, Bar plot of the number of goblet cells 
captured across paediatric/adult intestinal tissues. c, Dot plot of gene 
expression correlating with BEST2 expression across epithelial cell types from 
scRNA-seq dataset calculated using Jaccard Similarity measure.
Extended Data Fig. 6 | See next page for caption.
Article
Extended Data Fig. 6 | Epithelial cell types throughout intestinal life.  
a, UMAP of fetal (top) and pooled paediatric and adult (bottom) epithelial cells 
as in Fig. 2a, b coloured by gut region. b, Relative proportions of cell subtypes 
within total epithelial lineage as in Fig. 2a, b separated by donor age (row). Unit 
of age is years unless specified as weeks. c, Dot plot of TMPRSS2 and ACE2 
expression by epithelial cells of the paediatric (left) and adult (right) intestine. 
d, e, UMAP of enteroendocrine cells (subsetted from Fig. 2a, b) coloured by d, 
(top) developmental age of donor and (bottom) normalised expression of key 
genes of NPW+ enterochromaffin cells and e, overlaid with calculated RNA 
velocity (arrows) and pseudotime (colour). f, Immunohistochemical staining of 
KLK12 (antibody: CAB025473, n = 3), AFP (antibody; HPA010607, n = 4), CES1 
(antibody; HPA012023, n = 10), SLC18A1 (antibody; HPA063797, n = 12), GCH1 
(antibody; HPA028612, n = 8), NPW (antibody; HPA064874, n = 8) in intestinal 
sections from Human Protein Atlas (proteinatlas.org). Red arrows highlight 
positive staining and n represents biological replicates across intestinal 
regions. g, Heat map of top differentially expressed genes in tuft cells across 
epithelial cell types in scRNA-seq dataset. The legend indicates whether the 
gene has a known association with tuft cells (purple) or are novel (orange).  
h, Immunohistochemical staining of HPGDS (antibody: HPA024035, n = 8), 
PSTPIP2 (antibody: HPA040944, n = 8), BMX (antibody: CAB032495, n = 7), 
MYO1B (antibody: HPA060144, n = 6), FYB1 (antibody: CAB025336, n = 7), 
SH2D7 (antibody: HPA076728, n = 7), PLCG2 (antibody: HPA020099, n = 8) 
protein expression in small intestine from Human Protein Atlas (proteinatlas.
org). n represents biological replicates across intestinal regions. i, Dot plot 
showing expression of ITAM- and ITIM-linked receptors and receptor tyrosine 
kinases across tuft cells and pooled absorptive (TA and enterocytes) and 
secretory (Paneth, goblet and EECs) epithelial cells. j, Representative flow 
cytometry plots of FcγRII/III staining on EpCAM+SiglecF− (non-tuft epithelial 
cells) and EpCAM+SiglecF+ (tuft cells) cells and isotype staining of 
EpCAM+SiglecF+ cells. Numbers show the percentage of cells within the gate 
out of the total population.
Extended Data Fig. 7 | Tuft cells and PLCG2 activation. a, Heat map of 
expression of FCGR2A and downstream signalling molecules for epithelial cells 
with B and myeloid cell types included for reference. b, Representative 
brightfield images of paediatric intestinal organoid line (derived from healthy 
donors) in culture medium (undifferentiated) or differentiation medium 
(differentiated). Scale bar = 400 µm. c, Bar plot of relative expression of LGR5 
and MUC2 (left) (n = 3 from one patient) and other key mRNA (right) by 
intestinal organoids as in b (n = 6 from two patients). Mean with standard error 
of the mean (s.e.m.) is shown in bar plots, and statistics are calculated by 
multiple t-test analysis: *P < 0.05 and **P < 0.005. d, Representative bright-field 
images of paediatric intestinal organoid line (derived from healthy donors) 
without (NT) or with stimulation with inflammatory recombinant human 
proteins IFNγ or TNF. e, Heat map of normalised gene expression in scRNA-seq 
data of organoids from Crohn’s disease (n = 1) and control (n = 3) paediatric 
biopsies stimulated with inflammatory cytokines as in d. f, Per cent expression 
of indicated Fcγ receptors by SiglecF+EpCAM+ small intestinal tuft cells in wild 
type (n = 5) and DSS-treated (n = 3) mice from a single experiment determined 
by flow cytometry. Mean with standard deviation is shown and statistics are 
calculated by multiple t-test analysis **P < 0.01; NS = not significant.
Article
Extended Data Fig. 8 | See next page for caption.
Extended Data Fig. 8 | Cell types in the developing enteric nervous system. 
a, Multiplex smFISH images of SOX10,ERBB3,MPZ,PLP1 expressing ENCCs in the 
human small and large intestine at 6.5 PCW (Scale bar panels: main = 100 µm, 
zoom = 20 µm, n = 6). n here and below are biological replicates across regions. 
b, UMAP visualization of neural lineage cells in 6–11 and 12–17 PCW timepoints 
coloured by glial or neuronal score (left), cell cycle phase (middle) or 
pseudotime (right). Arrows show differentiation trajectory inferred from 
scVelo arrows as in Fig. 3a, b. c, Bar plot with relative abundance of cell types 
among ENCC-lineage populations as described in (Figure 3a, b) across 
intestinal regions and developmental timepoints. d, Heat map showing 
percentage of neural cells (6–17 PCW) described in this study (columns) 
matching with cells described in ref. 3 (rows). e, Multiplex smFISH imaging of 
SCGN/BNC2-expressing enteric neurons (left, scale bar = 50 µm) and  
BMP8B-expressing Glia 2 subtype (right, scale bar panels main = 100 µm, zoom 
= 50 µm) in the adult sample (55-60 years, terminal ileum, n=1) and f, Multiplex 
smFISH of DHH -expressing Glia 1 cells (n=2, left, scale bar panels main = 100 µm,  
zoom = 10 µm) and BMP8B-expressing Glia 2 subtype (n=2, right, scale bar 
panels main = 100 µm, zoom = 50 µm) in the fetal myenteric plexus from 15 PCW 
small intestines. The boxed area is shown at higher magnification below, and n 
represents biological replicates across regions. g, HOX gene expression across 
neural subsets in 6–11 PCW samples. In the red box are Glia 1 (DHH) cells from all 
regions. Genes highlighted in red are colon-specific. h, Dot plot of key HSCR-
associated ligand-receptor genes across the entire fetal scRNA-seq dataset. 
FPIL, fetal proximal ileum; FMIL, fetal middle ileum; FTIL, fetal terminal ileum; 
FLI, fetal large intestine.
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Extended Data Fig. 9 | Annotation of developing enteric neural cells.  
a, b, UMAP visualization of neural subsets combined from 6–17 PCW coloured 
by cell type annotation (a) or developmental stage (b). c, Bar plot showing 
regional distribution of neural subsets at 6–17 PCW. d, Dot plots with 
expression of key genes used to define enteric neuron subsets found at  
6–11 PCW (above) and 12–17 PCW (middle) and glial cells across 6–17 PCW.
Extended Data Fig. 10 | See next page for caption.
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Extended Data Fig. 10 | Identification of LTi-cell-like subset. a, Photo images 
of human intestinal gut and developing lymph nodes (arrows) at 8–17 PCW. 
Scale bar = 1 cm. b, Heat map of relative expression of key LTi defining and 
marker genes expressed by LTi-like cell types, NK cells and adult ILC3 as in 
Fig. 4a. Genes in red are highlighted in the schematic in Fig. 4b. c, Bar plot with 
productive TCRαβ chain in fetal T and innate lymphoid cell types as 
determined by V(D)J sequencing paired with scRNA-seq data. d, Dot plot of 
scaled expression of selected differentially expressed genes in fetal immune 
subsets from scRNA-seq dataset. e, Dot plot of expression of selected LTi-like 
genes in fetal liver ILCPs compared to LTi-like subsets in the gut. f, Bar graph 
showing the relative proportion of cell types among total T and innate 
lymphocyte population across developmental and adult gut regions and 
ages. FPIL, fetal proximal ileum; FMIL, fetal middle ileum; FTIL, fetal terminal 
ileum; FLI, fetal large intestine; FMLN, fetal mesenteric lymph node; DUO, 
duodenum; JEJ, jejunum; ILE, ileum; APD, appendix; CAE, caecum; ACL,  
ascending colon; TCL,transverse colon; DCL,descending colon; SCL,sigmoid 
colon; REC, rectum; MLN, mesenteric lymph node. g, Representative multiplex 
smFISH staining of fetal ileum tissue at 15 PCW showing three LTi-like subsets: 
NCR2+ ILC3, IL17A-expressing NCR− ILC3and SCN1B-expressing ILCP cells (Scale 
bar panels: main = 20 µm, zoom =5 µm, n = 2, biological replicates across 
regions). h, UMAP visualization of fetal T and innate lymphoid cells (subsetted 
from Fig. 4a) coloured by cell type and overlaid with RNA velocity arrows. Inset 
panel shows ILCP and LTi-like NCR+ ILC3 cells.
Extended Data Fig. 11 | LTi-like cells in plate based single-cell sequencing 
data of sorted cells from the human fetal intestine. a, UMAP visualization 
and feature plots of full-length Smart-seq2 data of flow cytometry-sorted 
CD45+ cells from second-trimester fetal tissue coloured by intestinal region or 
Leiden clustering. b, Dot plot of key marker gene expression in T and innate 
lymphoid cell subsets captured in Smart-seq2 experiment as in a. c, Bar plot of 
productive TCRαβ and TCRγδ chain in fetal T and innate lymphoid cell types as 
in a.
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Extended Data Fig. 12 | See next page for caption.
Extended Data Fig. 12 | Endothelial populations in the intestinal tract.  
a, UMAP visualization of endothelial cell populations in fetal, paediatric and 
adult scRNA-seq data coloured by cell-cycle score (left) or annotation (right). 
Dashed line outlines lymphatic endothelial cell (LEC) subsets. b, Relative 
proportions of subtypes within total endothelial lineage separated by 
intestinal region (above) and intestinal region (below). Unit of age is years 
unless specified as weeks. Region names are: FPIL, fetal proximal ileum;  
FMIL, fetal middle ileum; FTIL, fetal terminal ileum; FLI, fetal large intestine; 
FMLN, fetal mesenteric lymph node; DUO, duodenum; JEJ, jejunum; ILE, ileum; 
APD, appendix; CAE, caecum; ACL, ascending colon; TCL, transverse colon; 
DCL, descending colon; SCL, sigmoid colon; REC, rectum; MLN, mesenteric 
lymph node. c, Heat map with top differentially expressed genes in the LEC 
subsets. d, Violin plot of NF-kB signalling activation score across endothelial 
subpopulations. e, Dot plot with scaled expression of selected genes involved 
in lymphoid tissue organization and immune cell recruitment amongst 
lymphatic endothelial cell subsets and mLTo cells. f, H&E staining of cross-
section of fetal colon (15 PCW). Magnified panels show developing vessels 
(Scale bar panels: main = 200 µm, zoom = 20 µm, n = 9). g, Representative 
multiplex smFISH of PROX1 lymphatic vessels, CXCR5 ILC3 subsets and CXCL13-
expressing mLTo cells in the human fetal intestine at 15 PCW (scale bar = 
100 µm, n = 1). For f, g, n represents biological replicates across regions.
Article
Extended Data Fig. 13 | See next page for caption.
Extended Data Fig. 13 | Stromal in the intestinal tract. a, Heat map of top 
differentially expressed genes between follicular dendritic cells (FDCs) and T 
reticular cells (TRCs) and related stromal subsets. Each row is a cell. Arrows 
highlight key genes discussed in the text. b, Bar graph showing the relative 
proportion of cell types among the total stromal lineage across fetal and adult 
gut regions (top) and developmental ages (bottom). Unit of age is years unless 
specified as weeks. Region names are: FPIL, fetal proximal ileum; FMIL, fetal 
middle ileum; FTIL, fetal terminal ileum; FLI, fetal large intestine; FMLN, fetal 
mesenteric lymph node; DUO, duodenum; JEJ, jejunum; ILE, ileum; APD, 
appendix; CAE, caecum; ACL, ascending colon; TCL, transverse colon; DCL, 
descending colon; SCL, sigmoid colon; REC, rectum; MLN, mesenteric lymph 
node. c, Dot plot comparing key defining genes expressed across populations 
in a and fetal mesenchymal lymphoid tissue organiser (mLTo) cells. d, Bar plot 
showing number of mLTo in scRNA-seq dataset and coloured by gut region.  
e, UMAP visualization of stromal cells as in Fig. 4d showing co-expression of 
CXCL13, CCL19, and CCL21. f, Heat map of top differentially expressed genes of 
mLTo cells between different intestinal regions. Each row is a cell. g, Heat map 
of mean expression of ligand-receptor pairs in mLTo, LTi-like and LEC subset 
from scRNA-seq dataset as identified using CellphoneDB. h, Heat maps 
showing mean expression of curated immune recruitment signal genes by 
selected fetal stromal, epithelial and endothelial cell types (top) and their 
receptor expression in the immune cell types of the fetal gut and mLNs. Red 
arrows in f and h link cognate ligand receptor pairs.
Article
Extended Data Fig. 14 | See next page for caption.
Extended Data Fig. 14 | Intestinal B cells and BCR analysis. a, UMAP 
visualizations of scRNA-seq of subsetted B lineage cells from fetal samples. 
CLP, common lymphoid progenitor. b, Heat map with mean expression of 
differentially expressed gene in fetal B cell populations as in a. c, Violin plot of 
MHCII expression score of fetal B cell subsets as in a. c–e, UMAP visualization of 
fetal B lineage cells as in a coloured by (d) BCR isotype retrieved from 10x 
Genomics Chromium V(D)J sequencing and (e) 10x Genomics technology.  
f, UMAP visualizations of subsetted B lineage cells from paediatric and adult 
scRNA-seq samples. LZ, light zone; DZ, dark zone; GC, germinal centre.  
g, Relative proportions of subtypes within total B cell factions in the gut 
(above) and lymph nodes (below) separated by donor age (row) as in a and f. 
Unit of age is years unless specified as weeks. h, Estimated clonal abundances 
per donor for members of expanded B lineage cell clones in fetal and adult 
scRNA-seq datasets. i, Quantification of somatic hypermutation frequencies 
of IgH sequences from B lineage cells in fetal and adult scRNA-seq datasets as in 
h. j, k, Quantification of somatic hypermutation frequencies of IgH sequences 
( j) and estimated clonal abundances per donor for members of expanded B 
lineage cell clones (k) across fetal and adult gut regions. FPIL, fetal proximal 
ileum; FMIL, fetal middle ileum; FTIL, fetal terminal ileum; FLI, fetal large 
intestine; FMLN, fetal mesenteric lymph node; DUO, duodenum; JEJ, jejunum; 
ILE, ileum; APD,appendix; CAE, caecum; ACL,ascending colon; TCL, transverse 
colon; DCL, descending colon; SCL, sigmoid colon; REC, rectum;  
MLN, mesenteric lymph node. l, Binary count of co-occurrence of expanded B cell 
clones identified by single-cell V(D)J analysis shared across gut regions and donors.
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Extended Data Fig. 15 | See next page for caption.
Extended Data Fig. 15 | Ectopic lymphoid tissue formation in paediatric 
Crohn’s disease. a, Expression of mLTo gene markers by spatial coordinates in 
10x Genomics Visium data (left) and abundance of mLTo and ILC3 cells as 
estimated by cell2location34 (right) across 17 PCW (top) and 13 PCW fetal ileum 
(bottom). White boxes highlight predicted developing SLO tissue zones.  
b, Spatial mapping of scRNA-seq data to 10x Genomics Visium data showing 
estimated abundance (colour intensity) of cell subsets (colour) in fetal terminal 
ileum from 17 PCW (top), ileum from 13 PCW (bottom). c, Abundances of cell 
types as identified using non-negative matrix factorization (NMF) in tissue 
zones from Visium data as in b. Dot plot shows NMF weights of cell types 
(columns) across NMF factors (rows), which correspond to tissue zones 
(normalized across factors per cell type by dividing by maximum values).  
d, Heat map showing mean probability of immune and stromal cell types 
matching between fetal and Crohn’s disease scRNA-seq datasets. e, Heat map 
with expression of cytokines and chemokines in cells involved in tertiary 
lymphoid organ development of fetal (black) and functionally related cell 
types in paediatric Crohn’s disease (red). f, Forest plot of top cell types across 
fetal, paediatric (healthy and IBD), and adult data enriched for expression of 
genes associated with either Crohn’s disease or ulcerative colitis. All cell types 
in red have FDR < 10%. The number of cells for each sample (n = 159 samples in 
total with complete metadata) and coarse-grain cell type (9 different cell types 
in total) combination was modelled with a generalised linear mixed model with 
a Poisson outcome. Error bars show standard error for each factor as estimated 
using the numDeriv package.
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Reporting Summary
Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency 
in reporting. For further information on Nature Research policies, see our Editorial Policies and the Editorial Policy Checklist.
Statistics
For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement
A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one- or two-sided 
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested
A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons
A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) 
AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Give P values as exact values whenever suitable.
For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings
For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes
Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated
Our web collection on statistics for biologists contains articles on many of the points above.
Software and code
Policy information about availability of computer code
Data collection Software used include: 10x Genomics CellRanger (v3.0.0, v3.0.2) , 10x Genomics vdj (v.3.1.0 ), 10x Genomics SpaceRanger (v1.2.1 ), STAR 
aligner (Smart-seq2 data; version 2.5.1b). Visium spatial transcriptomics samples were aligned using 10x Genomics SpaceRanger (v1.2.1 ). 10X 
TCR sequences were aligned using 10x Genomics vdj (v.3.1.0 ) and Smartseq2 T cell receptor sequences were determined using TraCeR 
software (https://hub.docker.com/r/teichlab/tracer/). 
Data analysis Single cell data analysis was performed using Python (version 3), R (3.5.3), Pandas (version 0.24.2), limma (v3.46.0), NumPy (version 0.25.2), 
Anndata (version 0.6.19), Seaborn (version 0.11.0), and ScanPy (version 1.4 and 1.5.1). Ambient mRNA was removed using SoupX_1.4.8. 
Doublet removal using Scrublet (version 0.2.1). Batch correction- bbknn (version 1.3.9). TIgGER (v.03.1) , ChangeO (v.0.4.5), Shazam (v.0.1.11) 
were used for BCR analysis. Pseudotime calculated using scVelo (0.21) and Scanpy (1.5.1). CellPhoneDB (v2.0) was used for ligand-receptor 
analysis. Cell type enrichment analysis performed using miloR (https://github.com/MarioniLab/miloR). Flow cytometry data was visualised 
using FlowJo software (Version 10.7.0, Tree Star Inc.).GraphPadPrism 7 software was used for analysing FACS data. Additional custom codes 
used in this manuscript are available at Github: https://github.com/Teichlab/SpaceTimeGut, https://github.com/vitkl/fetal_gut_mapping/, 
https://github.com/natsuhiko/PHM. 
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors and 
reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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Policy information about availability of data
All manuscripts must include a data availability statement. This statement should provide the following information, where applicable: 
- Accession codes, unique identifiers, or web links for publicly available datasets 
- A list of figures that have associated raw data 
- A description of any restrictions on data availability
The expression data for fetal and adult regions is available in an interactive browsing website: www.gutcellatlas.org. Raw sequencing data are available at 
ArrayExpress (www.ebi.ac.uk/arrayexpress/; accession numbers E-MTAB-9543, E-MTAB-9536, E-MTAB-9532, E-MTAB-9533 and E-MTAB-10386).
Field-specific reporting
Please select the one below that is the best fit for your research. If you are not sure, read the appropriate sections before making your selection.
Life sciences Behavioural & social sciences  Ecological, evolutionary & environmental sciences
For a reference copy of the document with all sections, see nature.com/documents/nr-reporting-summary-flat.pdf
Life sciences study design
All studies must disclose on these points even when the disclosure is negative.
Sample size Sample size were determined by availability of donors within the sampling time-frame. No statistical methods were used to calculate 
appropriate sample size. We followed standards in the field and Human Cell Atlas criteria.
Data exclusions No exclusion was applied to the uploaded raw data in ArrayExpress. For the final count matrix, we excluded cells based on pre-established 
criteria for single cells. We excluded doublets and ow quality cells. This criteria is further summarised in the Methods section.
Replication Single-cell RNA sequencing was carried at on gut and lymph node tissue from 7 fetal donors and 4 adult diseased organ donors. All technical 
and biological replications of experiments were successful.
Randomization Sample collection was based on availability of fetal and warm-autopsy donors. Since we were following developmental stage of the intestinal 
tract, we allocated donor samples into developmental groups based on age. 
Blinding This study made no comparison between discreet groups for human participants, thus binding of investigators was not necessary. For mouse 
studies, Tuft and non-tuft epithelial cells from the same mice were analysed, thus binding was not relevant. 
Reporting for specific materials, systems and methods
We require information from authors about some types of materials, experimental systems and methods used in many studies. Here, indicate whether each material, 
system or method listed is relevant to your study. If you are not sure if a list item applies to your research, read the appropriate section before selecting a response. 
Materials & experimental systems




Animals and other organisms
Human research participants
Clinical data
Dual use research of concern
Methods





Antibodies used EpCAM-FITC (1:400, G8.8, Invitrogen, cat: 11-5791-82), anti-mouse CD45-Bv650 (1:200, 30-F11, BioLegend, cat: 103151), CD11b-
Bv421 (1:300, M1/70, BD Biosciences, cat: 562632), Siglec- F-APC (1:200, 1RNM44N, Invitrogen, cat: 12-1702-82), FcγRI-PE (1:200, 
X54-5/7.1, BioLegend, cat: 139303), FcγRIIB-PE (1:200, AT130-2, Invitrogen, cat: 12-0321-82), FcγRII/RIII-PE (1:200, 2.4G2, BD 
Biosciences, cat: 553145), FcγRIV-PE (1:200, 9E9, BioLegend, cat: 149503) and Rat IgG2b, κ isotype-PE-Cy7 (1:200, LOU/C, BD 
Biosciences, cat: 552849), Brilliant Violet 650 mouse anti-human CD45 (dilution: 1:200, Biolegend, cat: 304043), Alexa Fluor 700 
mouse anti-human CD4 (dilution: 1:200, Biolegend, cat: 300526), and APC-H7 mouse anti-human CD19 (dilution: 1:200, BD 
biosciences, cat: 560727).
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Validation EpCAM-FITC: Validated against TE-71 cell line compared to isotype control (Rat IgG2a K Isotype Control FITC). FACS plot shown on 
website. 
anti-mouse CD45-Bv650: Staining of C57BL/6 mouse splenocytes. FACS plot shown on website. 
CD11b-Bv421: Provided positive staining of C57BL/6 mouse bone marrow cells. FACS plot shown on website. 
Siglec- F-APC: Validated as staining of mouse thioglycolate-elicited peritoneal exudate cells. FACS plot shown on website. 
FcγRIIB-PE: positive staining of mouse splenocytes and compared to an isotype control. FACS plot shown on website. 
FcγRI-PE: Validated on C57BL/6 bone marrow cells and compared to isotype control (Armenian hamster IgG PE). FACS plot shown on 
website. 
FcγRII/RIII-PE: Validated by flow cytometric analysis of CD16/CD32 expression on mouse splenocytes. FACS plot shown on website. 
FcγRIV-PE: Positive staining of C57BL/6 bone marrow cells compared to isotype control (Armenian hamster IgG PE). FACS plot shown 
on website. 
Rat IgG2b, κ isotype-PE-Cy7: isotype control. 
Brilliant Violet 650 mouse anti-human CD45: Validated in human peripheral blood lymphocytes. FACS plot shown on website. 
Alexa Fluor 700 mouse anti-human CD4: Routinely tested and used for human peripheral blood lymphocytes. FACS plot shown on 
website. 
APC-H7 mouse anti-human CD19: Validated for CD19 expression on human lysed whole blood. FACS plot shown on website.
Animals and other organisms
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research
Laboratory animals C57BL/6 mice were obtained from Jackson Laboratories (Margate, UK) and housed in specific pathogen-free conditions at a 
Home Office-approved facility at the University of Cambridge. Mice were maintained with a 12 hour light/ 12 hour dark cycle, with 
temperature ranging from 20-24°C and humidity of 45-65%. Female mice aged 10-14 weeks were used in experiments.
Wild animals No wild animals were used in the study. 
Field-collected samples No field collected samples were used in the study.
Ethics oversight All procedures were carried out in accordance with ethical guidelines  with the United Kingdom Animals (Scientific Procedures) Act of 
1986 and approved by The University of Cambridge Animal Welfare and Ethical Review Body.
Note that full information on the approval of the study protocol must also be provided in the manuscript.
Human research participants
Policy information about studies involving human research participants
Population characteristics Human fetal gut samples were obtained from the Human Developmental Biology Resource (HDBR, www.hdbr.org) and age 
ranged between 7-17 post-conception weeks.  
Organ donors were either male or female and age ranged from 20-75 years. Ethnicity was not recorded, but expected to be 
primary Caucasian. 
Pediatric (5-12 years; either male or female) patient biopsy material used in intestinal organoid culture.
Recruitment Pediatric patient material used in intestinal organoid culture was obtained with informed consent from either parents and/or 
patients using age appropriate consent and assent forms as part of the ethically 
approved research study (REC-96/085).  
 
Human adult tissue was obtained by the Cambridge Biorepository of Translational 
Medicine from deceased transplant organ donors after ethical approval (reference 15/EE/0152, East of England—Cambridge 
South Research Ethics Committee) and informed consent from the donor families. 
 
Human fetal gut samples were obtained from the Human Developmental Biology Resource (HDBR, www.hdbr.org). The 
maternal consent was obtained through Newcastle hospital or through Cambridge Addenbrooke's hospital in collaboration 
with Roger A. Barker.  
Ethics oversight Procurement and study of fetal samples were approved by REC18/NE/0290- IRAS project ID: 250012, North East - Newcastle 
& North Tyneside 1 Research Ethics Committee and REC-96/085, East of England - Cambridge Central Research Ethics 
Committee.  
 
Pediatric patient material used in intestinal organoid culture was obtained with informed consent from either parents and/or 
patients using age appropriate consent and assent forms as part of the ethically approved research study (REC-12/EE/0482, 
NRES Committee East of England, Hertfordshire and REC-17/EE/0265- IRAS project ID: 222907, East of England - Cambridge 
South Research Ethics Committee). 
 
Human adult tissue was obtained by the Cambridge Biorepository of Translational Medicine from deceased transplant organ 
donors after ethical approval (reference 15/EE/0152, East of England—Cambridge South Research Ethics Committee) and 
informed consent from the donor families. 
Note that full information on the approval of the study protocol must also be provided in the manuscript.
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The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology
Sample preparation C57BL/6 mice received either normal drinking water or 2% (w/v) 36,000-50,000MW dextran sodium sulfate (DSS) (MP 
Biomedicals) to induce DSS colitis. For DSS treatment, mice received DSS water for 5 days followed by 14 days of normal 
drinking water, and then a final 5 days of 2% (w/v) DSS prior to being culled. 
Small intestines of mice were flushed of faecal content with ice-cold PBS, opened longitudinally, cut into 0.5 cm pieces, and 
washed by vortexing three times with PBS with 10mM HEPES. Tissue was then incubated with an epithelial stripping solution 
(RPMI-1640 with 2% (v/v) FCS, 10mM HEPES, 1mM DTT, and 5 mM EDTA) at 37°C for two intervals of 20 minutes to remove 
epithelial cells. The epithelial fraction was subsequently incubated at 37°C for 10 minutes with dispase (0.3 U/mL, Sigma- 
Aldrich) and passed through a 100μm filter to obtain a single-cell suspension. Cells were blocked for 20 minutes at 4°C with 
0.5% (v/v) heat-inactivated mouse/rat serum followed by extracellular staining in PBS at 4°C for 45 minutes with the following 
antibodies; EpCAM-FITC (1:400, G8.8, Invitrogen), CD45-Bv650 (1:200, 30-F11, BioLegend), CD11b-Bv421 (1:300, M1/70, BD 
Biosciences), Siglec-F-APC (1:200, 1RNM44N, Invitrogen), FcγRI-PE (1:200, X54-5/7.1, BioLegend), FcγRIIB-PE (1:200, AT130-2, 
Invitrogen), FcγRII/RIII-PE-Cy7 (1:200, 2.4G2, BD Biosciences), FcγRIV-PE (1:200, 9E9, BioLegend) and Rat IgG2b, κ isotype-
PECy7 (1:200, LOU/C, BD Biosciences). Cells were then stained with LIVE/DEAD Fixable Aqua Dead Cell Stain Kit (Thermo 
Fisher Scientific) for 20 minutes at room temperature, fixed with 2% PFA, and analysed on a CytoFLEX LX (Beckman Coulter) 
flow cytometer.
Instrument CytoFLEX LX (Beckman Coulter) flow cytometer.
Software Flow cytometry data was analyzed using FlowJo software (Version 10.7.0, Tree Star Inc.)
Cell population abundance EpCAM+SiglecF- cells that were defined as non-tuft epithelial cells were approximately 85% of live cells as analysed by flow 
cytometry. EpCAM+SiglecF+ cells made up 4%. This latter population was further assessed for CD11b cells in order to remove 
possible myeloid cells. Tuft cells from this gating were defined as EpCAM+SiglecF+CD11b- cells and represented 
approximately 94%. The purity of these populations was not determined as these cells were not sorted after analysis. 
 
These proportions are included in the gating strategy for these populations in Extended data 4j.
Gating strategy Mouse tuft cells were defined as EpCAM+SiglecF+CD11b- cells in epithelial fractions and non-tuft epithelial cells 
were defined as EpCAM+SiglecF-CD11b- cells in epithelial fractions.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
